WO2021213363A1 - Comprehensive intraocular lens implant for congenital cataract - Google Patents

Comprehensive intraocular lens implant for congenital cataract Download PDF

Info

Publication number
WO2021213363A1
WO2021213363A1 PCT/CN2021/088305 CN2021088305W WO2021213363A1 WO 2021213363 A1 WO2021213363 A1 WO 2021213363A1 CN 2021088305 W CN2021088305 W CN 2021088305W WO 2021213363 A1 WO2021213363 A1 WO 2021213363A1
Authority
WO
WIPO (PCT)
Prior art keywords
ring
intraocular lens
boss
adjustable
shaped
Prior art date
Application number
PCT/CN2021/088305
Other languages
French (fr)
Chinese (zh)
Inventor
杨愔
彭群
田奎
Original Assignee
西安眼得乐医疗科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 西安眼得乐医疗科技有限公司 filed Critical 西安眼得乐医疗科技有限公司
Publication of WO2021213363A1 publication Critical patent/WO2021213363A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1662Instruments for inserting intraocular lenses into the eye
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2002/1681Intraocular lenses having supporting structure for lens, e.g. haptics
    • A61F2002/16901Supporting structure conforms to shape of capsular bag
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/0097Coating or prosthesis-covering structure made of pharmaceutical products, e.g. antibiotics

Definitions

  • the present invention mainly relates to the technical field of ophthalmic intraocular lens, and more specifically relates to an integrated intraocular lens implant for congenital cataract.
  • the most basic function of the human eye is to transmit light through the cornea, the transparent refractive part at the front of the eye, and then gather on the retina after imaging through the natural lens to achieve visual function.
  • the quality of the focused image depends on many factors, including the size and shape of the eye and the transparency of the cornea and natural lens. Aging, heredity, immune and metabolic abnormalities, trauma and other reasons cause metabolic disorders in the natural lens, leading to protein denaturation of the natural lens. This phenomenon is called cataract in medicine.
  • the most effective way to treat cataracts is to surgically remove the natural lens and then replace it with an artificial lens. Most of the cataract lens is removed by a surgical procedure-phacoemulsification.
  • the ultra-emulsion probe needs to go deep into the small incision of the anterior capsular bag to break the cloudy natural lens and cortex into chylo, and then suck out the chylo with the aid of a suction and perfusion system. After the cloudy natural lens is removed, an intraocular lens is implanted.
  • An intraocular lens is an artificial lens that can be implanted in the eye. After the turbid natural lens is removed during cataract surgery, the artificial lens is implanted into the eye to replace the original natural lens for vision correction. Replacement of intraocular lens is currently the most effective treatment for cataract.
  • the most commonly used intraocular lens in the market is an open-loop intraocular lens, such as the SN60WF intraocular lens produced by ALCON, the ZCB00 intraocular lens produced by AMO, etc.
  • These intraocular lenses are mainly for senile cataract patients, and are they suitable for congenital cataract patients? There are many controversies.
  • the average refractive power shift from infancy to adolescence is 5 to 6D, and the eye axis becomes longer, leading to more and more myopia. It is quite difficult to reach the ideal refractive power in adulthood. (5) Compared with ordinary aging intraocular lenses, the placement time of intraocular lenses in children is almost a lifetime, and the possibility of intraocular lens replacement is increased.
  • one method is to directly place an intraocular lens suitable for the child after the cataract surgery, leaving a 20% shortfall during the operation Diopter, after the operation, you must wear glasses to correct your vision. I hope that the offset can be compensated for in puberty.
  • the refractive results of this treatment method are often unsatisfactory, and there are still fibrosis and recurrence caused by the severe inflammatory reaction after the above-mentioned operation. It also makes surgery difficult for the required replacement intraocular lens and increases the risk of capsular bag damage.
  • Another method is to keep the capsular bag after the cataract removal operation, but do not place the intraocular lens to allow the baby to wear corrective glasses, and wait until the baby reaches a certain age before placing the intraocular lens.
  • This method is called secondary implantation.
  • the placement position of the secondary intraocular lens depends on the condition of the capsular bag after the operation. If the capsular bag is intact and there is no shrinkage, fibrosis or adhesion, the intraocular lens can be directly implanted into the capsular bag. This possibility is quite small. .
  • the capsular bag of most patients undergoes severe contraction, fibrosis, and adhesion after cataract surgery. The intraocular lens cannot be placed in the capsular bag at a later stage.
  • the intracapsular ring implanted in the capsular bag can not only maintain the shape of the capsular bag, but also reserve a place for the intraocular lens to be placed.
  • the intraocular lens implanted in the capsular bag has better long-term safety; therefore, the integrated intraocular lens implant composed of the intracapsular ring and the intraocular lens provides a new alternative for patients with congenital cataracts.
  • the invention provides an integrated intraocular lens implant for congenital cataracts.
  • the integrated intraocular lens implant consists of an adjustable intra-capsular ring and an intraocular lens arranged on the adjustable intra-capsular ring.
  • an adjustable intracapsular ring can be implanted before cataract removal.
  • the intracapsular ring maintains the contour of the pediatric capsular bag to the greatest extent.
  • the lens is implanted at the right time. It is also possible to implant the entire combination in one operation according to the needs of the patient.
  • Both the adjustable intracapsular ring and the intraocular lens can be made of biocompatible materials such as silica gel, polymethyl methacrylate, hydrophobic acrylate, and cross-linked polyolefin materials.
  • An integrated intraocular lens implant for congenital cataracts including an adjustable intracapsular ring and an intraocular lens assembled on the adjustable intracapsular ring;
  • the adjustable intracapsular ring includes a ring-shaped body and an artificial lens for assembling artificial
  • the boss of the lens is arranged on the inner surface of the ring-shaped body, the ring-shaped body has a closed-loop structure or a C-shaped open-loop structure. The circumference can be in contact with the inner surface of the capsular bag.
  • one intraocular lens or two intraocular lenses are assembled on the adjustable intracapsular ring.
  • the intraocular lens is assembled on the front side of the boss and/or the back side of the boss.
  • the ring-shaped body when the ring-shaped body is a C-shaped open-loop structure, the ring-shaped body is composed of a segment of arc structure; when the ring-shaped body is a closed-loop structure, the ring-shaped body is connected by two or more segments of arc structures through the connecting portion As a result, the connecting portion has a V-shaped or U-shaped structure, and the opening of the V-shaped or U-shaped structure faces outward.
  • a plurality of bosses are provided in the ring-shaped main body, and a notch groove is provided between two adjacent bosses; the thickness H1 of the ring-shaped main body is greater than the thickness H2 of the bosses.
  • the ring-shaped main body and the boss are integrally formed.
  • the outer surface of the ring-shaped body is a planar structure, a concave arc structure or a convex arc structure; the cross-sectional shape of the boss is a rectangle or a trapezoid.
  • the boss is provided with a first through hole; the first through hole is a waist-shaped, polygonal, or circular through hole, and the first through hole is used to ensure the flow of the aqueous humor from the front and rear or for placement Sustained release drugs.
  • the ring-shaped body is provided with a second through hole; the second through hole is a waist-shaped, polygonal or circular through hole, and the second through hole is used to ensure the flow of the aqueous humor from the front and rear or for placement Sustained release drugs.
  • annular body and/or the boss is provided with a blind hole for placing a slow-release drug, and the blind hole is waist-shaped, polygonal or circular.
  • the ring body, the boss and the intraocular lens are all made of biocompatible materials; no polymerizable dye is added or added to the biocompatible materials; the biocompatible materials
  • the materials are silica gel, polymethyl methacrylate, hydrophobic acrylate or cross-linked polyolefin materials.
  • the intraocular lens includes an optical surface and a loop; the optical surface of the intraocular lens is any one of a spherical surface, an aspheric surface, astigmatism or a multifocal optical surface, and the intraocular lens has two or more loops.
  • the adjustable intracapsular ring and the intraocular lens are implanted in the same operation.
  • the adjustable intracapsular ring and the intraocular lens are implanted separately in multiple operations.
  • the invention relates to a comprehensive intraocular lens implant for congenital cataracts, including an adjustable intracapsular ring and an intraocular lens arranged on the adjustable intracapsular ring.
  • the adjustable intracapsular ring is a specially designed intraocular lens
  • the ring which has a certain thickness, shape and elasticity, can maintain the contour and elasticity of the pediatric capsular bag after the cataract is removed, and prevent the capsular bag from being severely contracted due to the absence of natural crystals.
  • the intracapsular ring can not only produce corresponding size changes with the growth of the pediatric capsular bag, but also prevent the migration of epithelial cells. More importantly, the structure of the adjustable intracapsular ring is specially designed to accept the intraocular lens implanted later.
  • the adjustable intracapsular ring is used in the capsular bag to provide convenience for the second implantation of the intraocular lens. It is no longer necessary to put the loop of the intraocular lens into the ciliary sulcus, which greatly reduces the stimulation to the ciliary sulcus and reduces the possibility of pigmentation and glaucoma.
  • the intraocular lens placed on the adjustable intracapsular ring is used in conjunction with the adjustable intracapsular ring. It consists of an optical part and a loop part.
  • the optical part can be any spherical, aspheric or multifocal intraocular lens.
  • the design of the loop can be
  • the intraocular lens can be placed on the inner ring of the capsule, and the intraocular lens can be fixed in the center. It is possible to add through holes or/and blind holes on the inner ring of the capsule for placing sustained-release drugs to effectively reduce and control postoperative inflammation.
  • the intraocular lens placed on the adjustable intracapsular ring can be replaced according to the needs of the patient, and it can also be added to the adjustable intracapsular ring
  • An intraocular lens is used to change the diopter, because the adjustable intracapsular ring also reserves a place for the second artificial lens. The above methods can effectively solve the problem of continuous diopter changes in adolescent cataract patients.
  • FIG. 1 is a schematic diagram of the structure of the adjustable intracapsular ring described in Example 3;
  • Example 2 is a schematic diagram of the structure of the adjustable intracapsular ring described in Example 4.
  • FIG. 3 is a schematic diagram of the structure of the adjustable inner ring of the capsule according to the embodiment 5;
  • Example 4 is a schematic diagram of the structure of the adjustable intracapsular ring described in Example 6;
  • Fig. 5 is a schematic structural diagram of the adjustable intra-capsular ring of embodiment 7;
  • Example 6 is a schematic diagram of the structure of the adjustable inner ring of the capsule in Example 8.
  • FIG. 7 is a schematic diagram of the structure of the adjustable inner ring of the capsule according to the embodiment 9;
  • Fig. 9 is a partial enlarged view of a concave arc structure on the outer side of the ring body
  • Fig. 10 is a partial enlarged view of a convex arc structure on the outer side of the ring body
  • FIG. 11 is a partial enlarged view of the cross-sectional shape of the ring-shaped main body being a trapezoid
  • FIG. 12 is a schematic diagram of the structure of the adjustable intracapsular ring of embodiment 17;
  • FIG. 13 is a schematic diagram of the structure of the adjustable intracapsular ring of embodiment 18;
  • Example 14 is a schematic diagram of the structure of the adjustable intra-capsular ring described in Example 19;
  • 15 is a schematic diagram of the structure of the adjustable intracapsular ring of embodiment 20;
  • FIG. 16 is a schematic diagram of the structure of the adjustable intracapsular ring of embodiment 21;
  • 17 is a schematic diagram of the structure of the adjustable intra-capsular ring of embodiment 22;
  • Figure 18 is a schematic diagram of the meaning designation of the front side, the back side and the inner side of the ring body and the boss;
  • Example 19 is a schematic diagram of the structure of the integrated intraocular lens implant for congenital cataract described in Example 26;
  • Example 20 is a schematic diagram of the structure of the integrated intraocular lens implant for congenital cataract described in Example 27;
  • Example 21 is a schematic diagram of the structure of the integrated intraocular lens implant for congenital cataract described in Example 28;
  • 1 ring body, 11 arc structure, 12 connecting part, 13 second through hole, 2 boss, 21 notch groove, 22 first through hole, 23 blind hole, H1 thickness of ring body, H2 convex The thickness of the platform, the front side of the A1 ring body, the back side of the B1 ring body, the inner side of the C1 ring body, the outer side of the D1 ring body, the front side of the A2 boss, the back side of the B2 boss, The inner side of the C2 boss.
  • the integrated intraocular lens implant for congenital cataracts of the present invention includes an adjustable intracapsular ring 100 and an intraocular lens 200 assembled on the adjustable intracapsular ring 100.
  • the adjustable intracapsular ring 100 includes a ring A shaped body 1 and a boss 2 for assembling an intraocular lens.
  • the annular body 1, the boss 2, and the intraocular lens 200 of the adjustable intracapsular ring 100 are all made of biocompatible materials; the biocompatible materials may not be added or added with polymerizable dyes. When dyes of different colors are added, the manufactured adjustable intracapsular ring 100 presents different colors, so that the intracapsular ring can be clearly distinguished during surgical implantation.
  • the material with biocompatibility can be silica gel, polymethyl methacrylate, hydrophobic acrylate, and cross-linked polyolefin material.
  • the sustained-release medicine mentioned in the present invention can effectively reduce and control postoperative inflammation.
  • the shape of the first through hole 22, the second through hole 13 and the blind hole 23 of the present invention may be other shapes in addition to the shapes listed in this specification, as long as the functions described in the present invention can be realized.
  • the adjustable intracapsular ring of this embodiment includes a ring-shaped body 1 and a boss 2 for assembling an intraocular lens.
  • the boss 2 is provided on the inner side of the ring body 1.
  • the boss 2 is located at the lower part of the thickness of the ring body 1, the thickness H1 of the ring body 1 is greater than the thickness H2 of the boss 2, the boss The front side of 2 is lower than the front side of the ring body 1, and the rear side of the boss 2 is higher than the back side of the ring body 1.
  • the ring body 1 is a closed-loop structure, and the ring body 1 consists of two or two sections
  • the above arc structure 11 is connected by a connecting portion 12, the connecting portion 12 is a V-shaped or U-shaped structure, the opening of the V-shaped or U-shaped structure faces outward, and the ring-shaped body 1 and the boss 2 are One-piece structure.
  • the adjustable intracapsular ring of this embodiment includes a ring-shaped body 1 and a boss 2 for assembling an intraocular lens.
  • the boss 2 is provided on the inner surface of the ring body 1.
  • the boss 2 is located at the upper part of the thickness of the ring body 1, the thickness H1 of the ring body 1 is greater than the thickness H2 of the boss 2, the boss The front side of 2 is lower than the front side of the ring body 1, and the rear side of the boss 2 is higher than the back side of the ring body 1.
  • the ring body 1 has a C-shaped open-loop structure, and the ring body 1 is a section of circle.
  • the arc structure 11 is formed, and the ring-shaped body 1 and the boss 2 are integrally formed.
  • the adjustable intracapsular ring described in this embodiment is shown in Fig. 1, and includes a ring-shaped body 1 and a boss 2 for assembling an intraocular lens.
  • the ring-shaped body 1 and the boss 2 are an integral structure.
  • the main body 1 has a C-shaped open-loop structure, the boss 2 is provided on the inner side of the ring-shaped main body 1, and the ring-shaped main body 1 is composed of a section of arc structure 11, and the inner side of the ring-shaped main body 1 is provided with two protrusions.
  • a notch 21 is provided between the two bosses 2.
  • the thickness H1 of the ring body 1 is greater than the thickness H2 of the boss 2.
  • the boss 2 is located in the middle of the thickness of the ring body 1, and the front side of the boss 2 is low On the front side of the ring body 1, the back side of the boss 2 is higher than the back side of the ring body 1.
  • the outer circumference of the annular body 1 can contact the inner surface of the capsule.
  • the outer surface of the ring-shaped body 1 is a plane structure
  • the cross-sectional shape of the ring-shaped body 1 is a rectangle
  • the cross-sectional shape of the boss 2 is a rectangle.
  • the adjustable intracapsular ring described in this embodiment is shown in Fig. 2. It includes a ring-shaped body 1 and a boss 2 for assembling an intraocular lens.
  • the ring-shaped body 1 and the boss 2 are integrally formed.
  • the main body 1 has a closed-loop structure.
  • the boss 2 is provided on the inner side of the ring-shaped main body 1.
  • the ring-shaped main body 1 is formed by connecting two arc structures 11 through a connecting portion 12, and the connecting portion 12 is a V-shaped structure.
  • the opening of the V-shaped structure faces outward, the inner side of the ring-shaped body 1 is provided with two bosses 2, and a gap groove 21 is provided between the two bosses 2, and the thickness H1 of the ring-shaped body 1 is greater than that of the bosses.
  • the thickness of the boss 2 is H2
  • the boss 2 is located in the middle of the thickness of the ring body 1, the front side of the boss 2 is lower than the front side of the ring body 1, and the back side of the boss 2 is higher than the back side of the ring body 1.
  • the boss 2 is provided with a first through hole 22; the first through hole 22 is a waist-shaped through hole, and the first through hole 22 is used to ensure the flow of front and back aqueous humor or to place a slow-release drug .
  • the outer circumference of the annular body 1 can contact the inner surface of the capsule.
  • the cross-sectional shape of the annular body 1 is rectangular, and the cross-sectional shape of the boss 2 is rectangular.
  • the adjustable intracapsular ring described in this embodiment is shown in Fig. 3, and includes a ring-shaped body 1 and a boss 2 for assembling an intraocular lens.
  • the ring-shaped body 1 and the boss 2 are integrally formed.
  • the main body 1 has a C-shaped open-loop structure
  • the boss 2 is provided on the inner side of the ring-shaped main body 1
  • the ring-shaped main body 1 is composed of a section of arc structure 11, and the inner side of the ring-shaped main body 1 is provided with two protrusions.
  • a notch 21 is provided between the two bosses 2.
  • the thickness H1 of the ring body 1 is greater than the thickness H2 of the boss 2.
  • the boss 2 is located in the middle of the thickness of the ring body 1, and the front side of the boss 2 is low On the front side of the ring body 1, the back side of the boss 2 is higher than the back side of the ring body 1.
  • the boss 2 is provided with a first through hole 22; the first through hole 22 is a circular through hole, and the annular body 1 is provided with a second through hole 13, and the second through hole 13 It is a circular through hole, and the first through hole 22 and the second through hole 13 are used to ensure the flow of aqueous humor before and after or to place a slow-release drug.
  • the outer circumference of the annular body 1 can contact the inner surface of the capsule.
  • the cross-sectional shape of the annular body 1 is rectangular, and the cross-sectional shape of the boss 2 is rectangular.
  • the adjustable intracapsular ring described in this embodiment is shown in Fig. 4, and includes a ring-shaped body 1 and a boss 2 for assembling an intraocular lens.
  • the ring-shaped body 1 and the boss 2 are an integral structure.
  • the main body 1 has a C-shaped open-loop structure, and the boss 2 is provided on the inner side of the ring-shaped main body 1.
  • the arc shape of the boss 2 is different from that of the embodiment 3.
  • the ring-shaped main body 1 is composed of a circular arc structure 11,
  • the inner side of the ring-shaped body 1 is provided with two bosses 2, and a gap groove 21 is provided between the two bosses 2.
  • the thickness H1 of the ring-shaped body 1 is greater than the thickness H2 of the bosses 2, and the bosses 2 are located in the ring In the middle of the thickness of the main body 1, the front side of the boss 2 is lower than the front side of the ring body 1, and the back side of the boss 2 is higher than the back side of the ring body 1.
  • the boss 2 is provided with a first through hole 22; the first through hole 22 is a waist-shaped through hole, and the first through hole 22 is used to ensure the flow of front and back aqueous humor or to place a slow-release drug .
  • the outer circumference of the annular body 1 can contact the inner surface of the capsule.
  • the cross-sectional shape of the ring-shaped body 1 is rectangular.
  • the adjustable bladder inner ring of this embodiment is shown in Fig. 5.
  • the difference from embodiment 6 is that a second through hole 13 is provided on the annular body 1, and the second through hole 13 is circular Through holes, the second through holes 13 are used to ensure the flow of aqueous humor before and after or to place slow-release drugs.
  • the remaining features are the same as those described in Example 6.
  • the adjustable intracapsular ring of this embodiment is shown in Fig. 6, and includes a ring-shaped body 1 and a boss 2 for assembling an intraocular lens.
  • the ring-shaped body 1 and the boss 2 are an integral structure.
  • the main body 1 has a closed-loop structure.
  • the boss 2 is provided on the inner side of the ring-shaped main body 1.
  • the ring-shaped main body 1 is formed by connecting two arc structures 11 through a connecting portion 12, and the connecting portion 12 is a U-shaped structure.
  • the opening of the U-shaped structure faces outward, and two bosses 2 are provided on the inner side of the ring-shaped body 1.
  • the arc shape of the bosses 2 is different from that of the third embodiment, and a notch groove is provided between the two bosses 2 21.
  • the thickness H1 of the ring body 1 is greater than the thickness H2 of the boss 2.
  • the boss 2 is located in the middle of the thickness of the ring body 1.
  • the front side of the boss 2 is lower than the front side of the ring body 1, and the back of the boss 2
  • the side surface is higher than the rear side surface of the ring body 1.
  • the adjustable bladder inner ring of this embodiment is shown in Fig. 7.
  • the difference from embodiment 8 is that the boss 2 is provided with a first through hole 22; the first through hole 22 is a circular through hole.
  • the ring-shaped body 1 is provided with a second through hole 13, the second through hole 13 is a circular through hole, the first through hole 22 and the second through hole 13 are used to ensure the front and rear aqueous humor It can be used to place slow-release drugs to effectively ensure the flow of aqueous humor before and after.
  • the remaining features are the same as those described in Example 8.
  • the adjustable bladder inner ring of this embodiment is shown in Fig. 8.
  • the difference from embodiment 4 is that a second through hole 13 is provided on the annular body 1, and the second through hole 13 is circular Through holes, the second through holes 13 are used to ensure the flow of aqueous humor before and after or to place slow-release drugs.
  • the remaining features are the same as those described in Example 4.
  • the adjustable inner bag ring of this embodiment is different from the embodiment 4 in that the ring-shaped body 1 is provided with a second through hole 13, and the second through hole 13 is a waist-shaped through hole, which is effective Ensure the flow of aqueous humor before and after.
  • the remaining features are the same as those described in Example 4.
  • the adjustable bladder ring of this embodiment is different from the embodiment 4 in that the ring body 1 is provided with a second through hole 13, and the second through hole 13 is a polygonal through hole, which effectively guarantees The flow of aqueous humor before and after.
  • the remaining features are the same as those described in Example 4.
  • the adjustable bladder inner ring of this embodiment is different from the embodiment 8 in that the boss 2 is provided with a first through hole 22; the first through hole 22 is a polygonal through hole, which effectively guarantees the front and rear The flow of aqueous humor.
  • the remaining features are the same as those described in Example 8.
  • the adjustable inner balloon ring of this embodiment is different from the embodiment 4 in that the outer surface of the ring body 1 is a concave arc structure, as shown in Fig. 9 a partial enlarged view.
  • the remaining features are the same as those described in Example 4.
  • the adjustable inner balloon ring of this embodiment is different from the embodiment 4 in that the outer surface of the ring body 1 is a convex arc structure, as shown in Fig. 10, a partial enlarged view.
  • the remaining features are the same as those described in Example 4.
  • the adjustable inner balloon ring of this embodiment is different from the third embodiment in that the cross-sectional shape of the annular body 1 is a trapezoid, as shown in FIG. 11, a partial enlarged view, and the cross-sectional shape of the boss 2 is a trapezoid.
  • the remaining features are the same as those described in Example 4.
  • the adjustable inner ring of the capsule in this embodiment is shown in Fig. 12.
  • the difference from embodiment 4 is that the front side of the boss 2 is also provided with a blind hole 23 for placing a slow-release drug. It is circular, the inner surface of the boss 2 is provided with a blind hole 23 for placing slow-release drugs, the blind hole is a waist-shaped groove, and the front side of the ring-shaped body 1 is also provided with a blind hole 23 for placing the slow-release drug.
  • the blind hole 23 of the medicine, the blind hole is circular.
  • the adjustable bladder inner ring of this embodiment is shown in Fig. 13.
  • the difference from the embodiment 17 is that the outer surface of the ring body 1 is a concave arc structure.
  • the remaining features are the same as those described in Example 17.
  • the adjustable balloon inner ring of this embodiment is shown in Fig. 14.
  • the difference from embodiment 10 is that the outer surface of the ring body 1 is a convex arc structure; the front side of the boss 2 A blind hole 23 for placing a slow-release drug is also provided, the blind hole is circular, the inner side of the boss 2 is provided with a blind hole 23 for placing a slow-release drug, and the blind hole is a waist-shaped groove.
  • the remaining features are the same as those described in Example 10.
  • the adjustable balloon inner ring of this embodiment is shown in Fig. 15.
  • the difference from embodiment 3 is that the outer surface of the ring body 1 is a concave arc structure; the inner surface of the boss 2 is provided There is a blind hole 23 for placing sustained-release drugs, and the blind hole is a waist-shaped groove.
  • the remaining features are the same as those described in Example 3.
  • the adjustable sac inner ring of this embodiment is shown in Fig. 16.
  • the front side of the boss 2 is also provided with a blind hole 23 for placing a slow-release drug.
  • the inner surface of the boss 2 is provided with a blind hole 23 for placing sustained-release drugs
  • the blind hole is a waist-shaped groove
  • the ring-shaped body 1 is provided with a second through hole 13
  • the second through hole 13 is a circular through hole
  • the second through hole 13 is used to ensure the flow of aqueous humor or to place slow-release drugs.
  • the outer surface of the ring body 1 is a convex arc structure. The remaining features are the same as those described in Example 6.
  • the adjustable intracapsular ring of this embodiment is shown in Fig. 17, and includes a ring-shaped body 1 and a boss 2 for assembling an intraocular lens.
  • the ring-shaped body 1 and the boss 2 are an integral structure.
  • the main body 1 has a closed-loop structure.
  • the boss 2 is provided on the inner side of the ring-shaped main body 1.
  • the ring-shaped main body 1 is formed by connecting two arc structures 11 through a connecting portion 12, and the connecting portion 12 is a V-shaped structure.
  • the opening of the V-shaped structure faces outward, and the thickness of the connecting portion 12 is the same as the thickness of the annular body 1.
  • the inner side of the ring-shaped body 1 is provided with two bosses 2, and a gap groove 21 is provided between the two bosses 2.
  • the thickness H1 of the ring-shaped body 1 is greater than the thickness H2 of the bosses 2, and the bosses 2 are located in the ring At the lower part of the thickness of the shaped body 1, the front side of the boss 2 is lower than the front side of the ring body 1, and the back side of the boss 2 and the back side of the ring body 1 are on the same plane.
  • the boss 2 is provided with a first through hole 22; the first through hole 22 is a waist-shaped through hole, and the first through hole 22 is used to ensure the flow of front and back aqueous humor or to place a slow-release drug .
  • the adjustable inner ring of the capsule in this embodiment is shown in Fig. 18.
  • the difference from the embodiment 10 is that the front side of the boss 2 is also provided with a blind hole 23 for placing a slow-release drug.
  • the inner surface of the boss 2 is provided with a blind hole 23 for placing a slow-release drug
  • the blind hole is a waist-shaped groove
  • the outer surface of the ring body 1 has a concave arc structure.
  • the integrated intraocular lens implant for congenital cataracts described in this embodiment includes an adjustable intracapsular ring 100 and an intraocular lens 200 assembled on the adjustable intracapsular ring 100;
  • the adjustable intracapsular ring 100 includes a ring A shaped body 1 and a boss 2 for assembling an intraocular lens.
  • the boss 2 is arranged on the inner side of the ring-shaped body 1.
  • the ring-shaped body 1 has a closed-loop structure.
  • the integrated intraocular lens implant for congenital cataracts described in this embodiment includes an adjustable intracapsular ring 100 and an intraocular lens 200 assembled on the adjustable intracapsular ring 100;
  • the adjustable intracapsular ring 100 includes a ring A shaped body 1 and a boss 2 for assembling an intraocular lens.
  • the boss 2 is arranged on the inner surface of the ring body 1.
  • the ring body 1 has a C-shaped open ring structure.
  • the integrated intraocular lens implant for congenital cataract described in this embodiment is shown in Fig. 19, which includes an adjustable intracapsular ring 100 and an intraocular lens 200 assembled on the adjustable intracapsular ring 100;
  • the ring 100 includes a ring body 1 and a boss 2 for assembling an intraocular lens.
  • the boss 2 is arranged on the inner surface of the ring body 1.
  • the ring body 1 has a C-shaped open ring structure. After the inner ring is implanted in the capsular bag, the outer circumference of the annular body 1 can contact the inner surface of the capsular bag.
  • two different types of intraocular lenses 200 are assembled on the front side of the boss 2 and the back side of the boss 2 of the adjustable intracapsular ring 100.
  • the optical surface of the intraocular lens 200 can be spherical, aspherical, astigmatic or multi-faceted. There are two haptics of the intraocular lens 200 for any one of the optical surfaces such as the focal point.
  • the difference between the adjustable inner balloon ring 100 used in this embodiment and the adjustable inner balloon ring 100 described in Example 6 is that the upper surface of the boss 2 is also provided with a blind hole 23, and the boss 2 A blind hole 23 is provided on the inner side of the ring, and a blind hole 23 is also provided on the ring-shaped body 1.
  • the blind hole 23 is used for placing sustained-release drugs.
  • the remaining features are the same as those described in Example 6.
  • the integrated intraocular lens implant for congenital cataract described in this embodiment is shown in Fig. 20, which includes an adjustable intracapsular ring 100 and an intraocular lens 200 assembled on the adjustable intracapsular ring 100; the adjustable intracapsular
  • the ring 100 includes a ring body 1 and a boss 2 for assembling an intraocular lens.
  • the boss 2 is arranged on the inner side of the ring body 1.
  • the ring body 1 is a closed ring structure. After being inserted into the capsular bag, the outer circumference of the annular body 1 can be in contact with the inner surface of the capsular bag.
  • an intraocular lens 200 is assembled on the front side of the boss 2 of the adjustable intracapsular ring 100.
  • the optical surface of the intraocular lens 200 can be any one of spherical, aspherical, astigmatic or multifocal optical surfaces.
  • the intraocular lens There are 2 loops of 200.
  • the adjustable inner bag ring 100 used in this embodiment is different from the embodiment 9 in that the inner surface of the boss 2 is provided with a blind hole 23.
  • the blind hole 23 is used for placing sustained-release drugs.
  • the remaining features are the same as those described in Example 9.
  • the integrated intraocular lens implant for congenital cataract described in this embodiment is shown in Fig. 21. It includes an adjustable intracapsular ring 100 and an intraocular lens 200 assembled on the adjustable intracapsular ring 100;
  • the ring 100 includes a ring body 1 and a boss 2 for assembling an intraocular lens.
  • the boss 2 is arranged on the inner surface of the ring body 1.
  • the ring body 1 has a C-shaped open ring structure. After the inner ring is implanted in the capsular bag, the outer circumference of the annular body 1 can contact the inner surface of the capsular bag.
  • an intraocular lens 200 is assembled on the back side of the boss 2 of the adjustable intracapsular ring 100.
  • the optical surface of the intraocular lens 200 can be any one of spherical, aspherical, astigmatic or multifocal optical surfaces.
  • the intraocular lens There are 2 loops of 200.
  • the adjustable inner balloon ring 100 used in this embodiment is the adjustable inner balloon ring 100 described in Embodiment 21.
  • phacoemulsification is used to remove the cloudy natural lens of the cataract patient, and then select the adjustable intracapsular ring 100 suitable for the size of the patient's capsular bag, and slowly push the intracapsular ring into the patient with tweezers or a special intracapsular injection device. Inside the bag, and adjust the position of the adjustable inner ring 100;
  • an intraocular lens 200 can be placed on the front or back side of the boss 2 of the adjustable intracapsular ring 100 when appropriate.
  • the intraocular lens 200 placed on the adjustable intracapsular ring 100 can be replaced at an appropriate time according to the needs of the patient, or another intraocular lens 200 can be added to the intracapsular ring to change the diopter.
  • the manufacturing method of the integrated intraocular lens implant for congenital cataract of the present invention is the manufacturing method of the integrated intraocular lens implant for congenital cataract of the present invention.
  • Adjustable inner sac ring 100 It is injection molded into a blank, processed by mechanical processing, and then subjected to post-processing such as grinding, polishing, cleaning, and drying. After that, it is packaged and sterilized, and it is implanted into the human eye sac through a special injection device or tweezers. Inside.
  • Intraocular lens 200 After injection molding, the blank is mechanically processed, and then chemical treatment, cleaning, drying and other post-treatments are carried out, and then packaged and sterilized. After the intraocular lens bolus is implanted in the human eye capsule, it is placed in the capsule One side of the inner ring.
  • the intraocular lens 200 of the present invention may be an intraocular lens in the prior art or a new type of intraocular lens developed in the future. As long as it can be assembled on the boss 2 of the adjustable intracapsular ring 100 of the present invention, it is protected by the present invention. Design concept.
  • the integrated intraocular lens implant for congenital cataracts of the present invention includes an adjustable intracapsular ring 100 and an intraocular lens 200 assembled on the adjustable intracapsular ring 100.
  • the adjustable intracapsular ring 100 An intraocular lens 200 can be mounted on it. According to the actual situation of the patient, place an intraocular lens 200 on the anterior or posterior side of the boss 2 of the adjustable intracapsular ring 100.
  • the intraocular lens can also be replaced according to the needs of the patient, and another intraocular lens can be added to the boss 2 200 to adjust the diopter of the patient.
  • the combined implants can be implanted separately.
  • the adjustable intracapsular ring 100 is first implanted to protect the pediatric capsular bag.
  • the intraocular lens 200 can be implanted in the adjustable intracapsular ring 100.
  • the adjustable intracapsular ring 100 and the intraocular lens 200 can also be implanted in one operation.
  • the unique structural design of the adjustable intracapsular ring 100 of the present invention enables the intracapsular ring to produce corresponding size changes with the growth of the pediatric capsular bag, maintain the circular contour of the capsular bag, and help maintain the normal lens capsular bag Physiological position to prevent tilt and eccentricity of the intraocular lens.
  • the intraocular lens is in contact with the inner surface of the adjustable intracapsular ring instead of the capsular bag, it reduces the surgical difficulty that the intraocular lens may adhere to the capsular bag and is not easy to remove.
  • the outer circumference of the ring body 1 can contact the inner surface of the capsular bag, which can play a barrier function and contact inhibition effect, prevent the proliferation and migration of lens epithelial cells, and reduce After the occurrence of cataract, to prevent the occurrence of turbidity of the capsule before and after.
  • the boss 2 is provided with a first through hole 22; the first through hole 22 is a waist-shaped, polygonal or circular through hole, and the first through hole 22 is used to ensure the front and back of the aqueous humor It is mobile or used to place sustained-release drugs.
  • the annular body 1 is provided with a second through hole 13; the second through hole 13 is a waist-shaped, polygonal, or circular through hole, and the second through hole 13 is used to ensure the flow or use of aqueous humor before and after. Place sustained-release drugs.
  • the annular body 1 and/or the boss 2 are provided with a blind hole 23 for placing a slow-release drug, and the blind hole is waist-shaped, polygonal or circular.
  • the ring-shaped body 1 and the boss 2 are made of biocompatible materials; the biocompatible materials may not be added or added with polymerizable dyes, and when necessary, they may have biological phases.
  • the polymerizable dye is added to the capacitive material, the adjustable intracapsular ring of the present invention presents different colors, which is convenient for making the intracapsular ring clearly distinguishable during surgical implantation.

Abstract

A comprehensive intraocular lens implant for congenital cataract. The comprehensive intraocular lens implant comprises an adjustable intracapsular ring (100) and a common intraocular lens (200) assembled on the adjustable intracapsular ring (100). The adjustable intracapsular ring (100) comprises a ring-shaped body (1) and a boss (2) used for assembling the intraocular lens (200), the boss (2) is provided on the inner side surface of the ring-shaped body (1), and the ring-shaped body (1) is of a closed-ring structure or a C-shaped open-ring structure. The adjustable intracapsular ring (100) is an intracapsular ring which is specially designed and has certain thickness, shape and elasticity, the contour and elasticity of an infant capsular bag after the natural crystalline lens is removed can be kept, and capsular bag contraction caused by no natural crystalline lens is prevented. The adjustable intracapsular ring (100) not only can generate a corresponding size change along with the growth of the infant capsular bag to prevent migration of epithelial cells, but also can be used for fixing an intraocular lens implanted in the later period, and provides convenience for secondary implantation of the intraocular lens in the capsular bag.

Description

一种用于先天性白内障的综合人工晶状体植入体A comprehensive intraocular lens implant for congenital cataract 技术领域Technical field
本发明主要涉及眼科人工晶状体技术领域,更具体的涉及一种用于先天性白内障的综合人工晶状体植入体。The present invention mainly relates to the technical field of ophthalmic intraocular lens, and more specifically relates to an integrated intraocular lens implant for congenital cataract.
背景技术Background technique
人眼最基本的功能是通过眼睛最前面的透明折光部分-角膜来传输光线,然后通过自然晶状体成像后聚集在视网膜上,以实现视觉功能。聚焦的成像质量依赖于很多因素,包括眼睛的尺寸和形状以及角膜和自然晶状体的透明度。老化、遗传、免疫与代谢异常,外伤等原因引起放入自然晶状体代谢紊乱,导致自然晶状体蛋白质变性,医学上将这种现象称为白内障。目前治疗白内障最有效的方式就是手术摘除掉自然晶状体,然后置换上人工晶状体。大部分白内障晶状体通过一种外科手术-超声乳化术摘除掉。手术时,需要在前囊袋小切口处深入超乳探头将混浊的自然晶状体和皮质击碎为乳糜状后,借助抽吸灌注系统将乳糜状物吸出。混浊的自然晶状体摘除后再植入人工晶状体。The most basic function of the human eye is to transmit light through the cornea, the transparent refractive part at the front of the eye, and then gather on the retina after imaging through the natural lens to achieve visual function. The quality of the focused image depends on many factors, including the size and shape of the eye and the transparency of the cornea and natural lens. Aging, heredity, immune and metabolic abnormalities, trauma and other reasons cause metabolic disorders in the natural lens, leading to protein denaturation of the natural lens. This phenomenon is called cataract in medicine. At present, the most effective way to treat cataracts is to surgically remove the natural lens and then replace it with an artificial lens. Most of the cataract lens is removed by a surgical procedure-phacoemulsification. During the operation, the ultra-emulsion probe needs to go deep into the small incision of the anterior capsular bag to break the cloudy natural lens and cortex into chylo, and then suck out the chylo with the aid of a suction and perfusion system. After the cloudy natural lens is removed, an intraocular lens is implanted.
人工晶状体(IOL)是一种能植入眼内的人造透镜,在白内障手术摘除了浑浊的自然晶状体后,将人工晶状体植入眼内替代原来的自然晶状体进行视力矫正。置换人工晶状体是目前治疗白内障最有效的手段。目前市场上最常用的人工晶状体为开环式人工晶状体,比如ALCON生产的SN60WF型人工晶状体,AMO生产的ZCB00型人工晶状体等,这些人工晶状体主要针对老年性白内障患者,对先天性白内障患者是否合适,有众多争议,先天性白内障患者在世界人口中比例为0.01-0.06%,中国先天性白内障患者的比例为0.05%。对先天性白内障的小儿患者来说,去除白内障越早越好,因为白内障会阻碍视力的发育。但是是否在做白内障手术的同时就置换人工晶状体,或者置换什么样的人工晶状体都是颇有争议的。An intraocular lens (IOL) is an artificial lens that can be implanted in the eye. After the turbid natural lens is removed during cataract surgery, the artificial lens is implanted into the eye to replace the original natural lens for vision correction. Replacement of intraocular lens is currently the most effective treatment for cataract. At present, the most commonly used intraocular lens in the market is an open-loop intraocular lens, such as the SN60WF intraocular lens produced by ALCON, the ZCB00 intraocular lens produced by AMO, etc. These intraocular lenses are mainly for senile cataract patients, and are they suitable for congenital cataract patients? There are many controversies. The proportion of congenital cataract patients in the world population is 0.01-0.06%, and the proportion of congenital cataract patients in China is 0.05%. For pediatric patients with congenital cataract, the sooner the cataract is removed, the better, because cataract will hinder the development of vision. However, whether the intraocular lens is replaced at the same time as the cataract surgery, or what kind of intraocular lens is replaced is quite controversial.
两岁及两岁以上的小儿囊袋已接近成人,因此两岁以上做白内障手术及人工晶状体置换,是国际公认的治疗先天性白内障小儿患者的方法;但是2岁以下的婴儿放置人工晶状体主要有以下几问题:(1)术后炎症反应导致严重纤维化葡萄膜炎及致密纤维。(2)产生严重的后发障。(3)做二期植入将人工晶状体放置于睫状沟,导致继发性青光眼。(4)手术前生物测量困难导致屈光度计算不确定 性,,很难达到理想的屈光度。而且婴儿的屈光度在手术后迅速偏移,从婴儿期到青春期平均屈光度偏移为5到6D,眼轴变长,导致越来越近视。成年后达到理想的屈光度有相当大的困难。(5)和普通老化型人工晶状体相比,小儿的人工晶状体放置时间几乎是终生,需要置换人工晶状体的可能性增加。The capsular bag of children aged two years and older is close to adults. Therefore, cataract surgery and intraocular lens replacement for children over two years old are internationally recognized methods for the treatment of children with congenital cataract; The following problems: (1) Postoperative inflammation leads to severe fibrotic uveitis and dense fibers. (2) Severe late-onset obstacles. (3) Place the intraocular lens in the ciliary sulcus with secondary implantation, resulting in secondary glaucoma. (4) Difficulties in biometric measurement before surgery lead to uncertainty in the calculation of diopter, and it is difficult to achieve the ideal diopter. In addition, the baby's refractive power shifts rapidly after the operation. The average refractive power shift from infancy to adolescence is 5 to 6D, and the eye axis becomes longer, leading to more and more myopia. It is quite difficult to reach the ideal refractive power in adulthood. (5) Compared with ordinary aging intraocular lenses, the placement time of intraocular lenses in children is almost a lifetime, and the possibility of intraocular lens replacement is increased.
目前国际上针对小儿患者做先天性白内障手术及放置人工晶状体的方法主要有以下两种:一种方法是做完白内障手术后,直接放置尺寸适合小儿的人工晶状体,手术时预留20%的不足屈光度,手术完必须戴眼镜矫正视力,希望到了青春期可以补偿偏移的屈光度。这种治疗方法的屈光结果往往不理想,而且仍然存在着上述术后严重炎症反应引起的纤维化及再发障。也给需要的置换人工晶状体造成手术难度,增加了囊袋破损的风险。At present, there are two main methods for congenital cataract surgery and intraocular lens placement for pediatric patients in the world: one method is to directly place an intraocular lens suitable for the child after the cataract surgery, leaving a 20% shortfall during the operation Diopter, after the operation, you must wear glasses to correct your vision. I hope that the offset can be compensated for in puberty. The refractive results of this treatment method are often unsatisfactory, and there are still fibrosis and recurrence caused by the severe inflammatory reaction after the above-mentioned operation. It also makes surgery difficult for the required replacement intraocular lens and increases the risk of capsular bag damage.
另一种方法是做完白内障切除手术后,保留囊袋,但是不放置人工晶状体让婴儿戴矫正眼镜,等婴儿到了一定的年龄再放人工晶状体,这种方式称二次植入。二次植入的人工晶状体放置位置取决于术后囊袋的状况,如果囊袋完好,没有出现收缩、纤维化及粘连的现象,可以直接将人工晶状体植入囊袋,这种可能性相当小。大部分患者的囊袋在白内障术后产生严重收缩、纤维化及粘连,人工晶状体后期无法放入囊袋,大部分二次植入的人工晶状体都只能放在囊袋前睫状沟里。睫状沟放置人工晶状体的长期安全性一直是有相当争议的,比较严重的副作用是继发性青光眼,有关文献发现小儿白内障患者二次将人工晶状体植入至睫状沟是产生继发性青光眼的主要危险因子。Another method is to keep the capsular bag after the cataract removal operation, but do not place the intraocular lens to allow the baby to wear corrective glasses, and wait until the baby reaches a certain age before placing the intraocular lens. This method is called secondary implantation. The placement position of the secondary intraocular lens depends on the condition of the capsular bag after the operation. If the capsular bag is intact and there is no shrinkage, fibrosis or adhesion, the intraocular lens can be directly implanted into the capsular bag. This possibility is quite small. . The capsular bag of most patients undergoes severe contraction, fibrosis, and adhesion after cataract surgery. The intraocular lens cannot be placed in the capsular bag at a later stage. Most of the second-implanted intraocular lenses can only be placed in the anterior ciliary sulcus of the capsular bag. The long-term safety of intraocular lens placement in the ciliary sulcus has always been quite controversial. The more serious side effect is secondary glaucoma. The relevant literature has found that the second time the intraocular lens is implanted into the ciliary sulcus in pediatric cataract patients produces secondary glaucoma. The main risk factors for
因此,提供一种可以满足小儿先天性白内障患者要求的综合人工晶状体植入体,具有相当大的意义。Therefore, it is of great significance to provide a comprehensive intraocular lens implant that can meet the requirements of pediatric congenital cataract patients.
发明内容Summary of the invention
(一)本发明要解决的技术问题(1) Technical problems to be solved by the present invention
(1)解决目前大部分先天性白内障病人因需要二次植入至睫状沟人工晶状体而引起的继发性青光眼。植入囊袋内的囊内环不但可以保持囊袋形状,而且给需要放置人工晶状体预留了放置位置。植入囊袋内的人工晶状体具有更好的长期安全性;因此,由囊内环与人工晶状体组合而成的综合人工晶状体植入体,为先天性白内障病人提供了一个新的备选方案。(1) Solve the secondary glaucoma caused by most congenital cataract patients who need to be implanted into the ciliary sulcus intraocular lens twice. The intracapsular ring implanted in the capsular bag can not only maintain the shape of the capsular bag, but also reserve a place for the intraocular lens to be placed. The intraocular lens implanted in the capsular bag has better long-term safety; therefore, the integrated intraocular lens implant composed of the intracapsular ring and the intraocular lens provides a new alternative for patients with congenital cataracts.
(2)解决因小儿术前生物测量困难带来的屈光度不确定性以及因小儿的屈光度术后的偏移带来的屈光矫正不准的问题;为病人提供了更合适的的置换人工晶状体的方案。(2) Solve the problem of inaccuracy of refractive power caused by the difficulty of preoperative biometric measurement in children and the problem of inaccurate refractive correction caused by the deviation of children's refractive power after surgery; provide patients with more suitable replacement intraocular lenses Plan.
(3)减轻术后炎症反应导致的纤维化,减轻后发障;(3) Reduce fibrosis caused by postoperative inflammatory reaction, and alleviate hindrance;
(4)小儿人工晶状体植入囊袋放置时间长,需要置换人工晶状体的可能性都比老年性白内障病人高得多,同时长期置放的人工晶状体置换手术难度会由于纤维化而增加。减少因置换人工晶状体而造成的囊袋破裂的风险。(4) Pediatric intraocular lens implantation capsular bag is placed for a long time, and the possibility of intraocular lens replacement is much higher than that of senile cataract patients. At the same time, the difficulty of long-term intraocular lens replacement surgery will increase due to fibrosis. Reduce the risk of capsular bag rupture caused by the replacement of the intraocular lens.
本发明提供一种用于先天性白内障的综合人工晶状体植入体,该综合人工晶状体植入体由可调式囊内环和设置在可调式囊内环上的人工晶状体组成。根据患者实际情况,可以在做白内障移除时先植入可调式囊内环,该囊内环最大程度的保持小儿囊袋轮廓,囊内环上有可以接受人工晶状体的结构,后期再将人工晶状体在合适的时候植入。也可以根据患者需要将整个组合在一次手术中全部植入。为患者提供了可以置换人工晶状体的备选方案。该可调式囊内环和人工晶状体均可以由硅胶、聚甲基丙烯酸甲酯、疏水性丙烯酸酯、交联聚烯烃材料等具有生物相容性的材料制成。The invention provides an integrated intraocular lens implant for congenital cataracts. The integrated intraocular lens implant consists of an adjustable intra-capsular ring and an intraocular lens arranged on the adjustable intra-capsular ring. According to the actual situation of the patient, an adjustable intracapsular ring can be implanted before cataract removal. The intracapsular ring maintains the contour of the pediatric capsular bag to the greatest extent. There is a structure on the intracapsular ring that can accept intraocular lenses. The lens is implanted at the right time. It is also possible to implant the entire combination in one operation according to the needs of the patient. Provide patients with an alternative to replace the intraocular lens. Both the adjustable intracapsular ring and the intraocular lens can be made of biocompatible materials such as silica gel, polymethyl methacrylate, hydrophobic acrylate, and cross-linked polyolefin materials.
(二)本发明的实现过程如下:(2) The implementation process of the present invention is as follows:
一种用于先天性白内障的综合人工晶状体植入体,包括可调式囊内环和装配在可调式囊内环上的人工晶状体;所述可调式囊内环包括环状主体和用于装配人工晶状体的凸台,所述凸台设置在环状主体的内侧面,所述环状主体为闭环结构或C形开环结构,当可调式囊内环植入囊袋后,环状主体的外圆周可与囊袋内侧面接触。An integrated intraocular lens implant for congenital cataracts, including an adjustable intracapsular ring and an intraocular lens assembled on the adjustable intracapsular ring; the adjustable intracapsular ring includes a ring-shaped body and an artificial lens for assembling artificial The boss of the lens, the boss is arranged on the inner surface of the ring-shaped body, the ring-shaped body has a closed-loop structure or a C-shaped open-loop structure. The circumference can be in contact with the inner surface of the capsular bag.
进一步,所述可调式囊内环上装配一个人工晶状体或两个人工晶状体。Further, one intraocular lens or two intraocular lenses are assembled on the adjustable intracapsular ring.
进一步,所述人工晶状体装配在凸台的前侧面和/或凸台的后侧面上。Further, the intraocular lens is assembled on the front side of the boss and/or the back side of the boss.
进一步,当环状主体为C形开环结构时,环状主体为一段圆弧结构构成;当环状主体为闭环结构时,环状主体由两段或两段以上圆弧结构通过连接部连接而成,所述连接部为V形或U形结构,所述V形或U形结构的开口朝外。Further, when the ring-shaped body is a C-shaped open-loop structure, the ring-shaped body is composed of a segment of arc structure; when the ring-shaped body is a closed-loop structure, the ring-shaped body is connected by two or more segments of arc structures through the connecting portion As a result, the connecting portion has a V-shaped or U-shaped structure, and the opening of the V-shaped or U-shaped structure faces outward.
进一步,所述环状主体内设置有若干个凸台,相邻两个凸台之间设置有缺口槽;所述环状主体的厚度H1大于凸台的厚度H2。Further, a plurality of bosses are provided in the ring-shaped main body, and a notch groove is provided between two adjacent bosses; the thickness H1 of the ring-shaped main body is greater than the thickness H2 of the bosses.
进一步,所述环状主体与凸台为一体成型结构。Further, the ring-shaped main body and the boss are integrally formed.
进一步,所述环状主体的外侧面为平面结构、内凹的圆弧结构或外凸的圆弧 结构;所述凸台的截面形状为矩形或梯形。Further, the outer surface of the ring-shaped body is a planar structure, a concave arc structure or a convex arc structure; the cross-sectional shape of the boss is a rectangle or a trapezoid.
进一步,所述凸台上设置有第一通孔;所述第一通孔为腰形、多边形或圆形的通孔,所述第一通孔用于保证前后房水的流动或用于放置缓释药物。Further, the boss is provided with a first through hole; the first through hole is a waist-shaped, polygonal, or circular through hole, and the first through hole is used to ensure the flow of the aqueous humor from the front and rear or for placement Sustained release drugs.
进一步,所述环形主体上设置有第二通孔;所述第二通孔为腰形、多边形或圆形的通孔,所述第二通孔用于保证前后房水的流动或用于放置缓释药物。Further, the ring-shaped body is provided with a second through hole; the second through hole is a waist-shaped, polygonal or circular through hole, and the second through hole is used to ensure the flow of the aqueous humor from the front and rear or for placement Sustained release drugs.
进一步,所述环形主体和/或凸台上设置有用于放置缓释药物的盲孔,所述盲孔为腰形、多边形或圆形。Further, the annular body and/or the boss is provided with a blind hole for placing a slow-release drug, and the blind hole is waist-shaped, polygonal or circular.
进一步,所述环状主体、凸台和人工晶状体均由具有生物相容性的材料制成;所述具有生物相容性的材料中不添加或添加可聚合染料;所述具有生物相容性的材料为硅胶、聚甲基丙烯酸甲酯、疏水性丙烯酸酯或交联聚烯烃材料。Further, the ring body, the boss and the intraocular lens are all made of biocompatible materials; no polymerizable dye is added or added to the biocompatible materials; the biocompatible materials The materials are silica gel, polymethyl methacrylate, hydrophobic acrylate or cross-linked polyolefin materials.
进一步,所述人工晶状体包括光学面和襻;所述人工晶状体的光学面为球面、非球面、散光或多焦点光学面中任意一种,所述人工晶状体的襻为2个或2个以上。Further, the intraocular lens includes an optical surface and a loop; the optical surface of the intraocular lens is any one of a spherical surface, an aspheric surface, astigmatism or a multifocal optical surface, and the intraocular lens has two or more loops.
进一步,在使用过程中,按患者的情况,可调式囊内环和人工晶状体在同一次手术中植入。Furthermore, during use, according to the patient's condition, the adjustable intracapsular ring and the intraocular lens are implanted in the same operation.
进一步,在使用过程中,按患者的情况,可调式囊内环和人工晶状体在多次手术中分别植入。Furthermore, during use, according to the patient's condition, the adjustable intracapsular ring and the intraocular lens are implanted separately in multiple operations.
(三)本发明的积极效果:(3) Positive effects of the present invention:
本发明涉及的一种用于先天性白内障的综合人工晶状体植入体包括可调式囊内环和设置在可调式囊内环上的人工晶状体,可调式囊内环为一个有特殊设计的囊内环,该环有一定的厚度、形状及弹性,可以保持去掉白内障之后小儿囊袋的轮廓和弹性,阻止因无自然晶体而造成的囊袋严重收缩。该囊内环不但可以随着小儿囊袋的生长产生相应的尺寸变化,同时也可以阻止上皮细胞的迁移。更重要的是可调式囊内环的结构做了特殊设计,可以用来接受后期植入的人工晶状体,该可调式囊内环用在囊袋内为二次植入人工晶状体提供了方便。不再需要将人工晶状体的襻放入睫状沟,大大减少了对睫状沟的刺激,减少了色素沉着和青光眼发生的可能性。放置在可调式囊内环上的人工晶状体与可调式囊内环配合使用,由光学部分和襻部分组成,光学部分可以是任何球面、非球面或者多焦光学面的人工晶状体,襻的设计可以使人工晶状体可以放置在囊内环上,并使人工晶状体 居中固定。可以通过在囊内环上增加通孔或/和盲孔,用于放置缓释药物来有效减少和控制术后炎症。The invention relates to a comprehensive intraocular lens implant for congenital cataracts, including an adjustable intracapsular ring and an intraocular lens arranged on the adjustable intracapsular ring. The adjustable intracapsular ring is a specially designed intraocular lens The ring, which has a certain thickness, shape and elasticity, can maintain the contour and elasticity of the pediatric capsular bag after the cataract is removed, and prevent the capsular bag from being severely contracted due to the absence of natural crystals. The intracapsular ring can not only produce corresponding size changes with the growth of the pediatric capsular bag, but also prevent the migration of epithelial cells. More importantly, the structure of the adjustable intracapsular ring is specially designed to accept the intraocular lens implanted later. The adjustable intracapsular ring is used in the capsular bag to provide convenience for the second implantation of the intraocular lens. It is no longer necessary to put the loop of the intraocular lens into the ciliary sulcus, which greatly reduces the stimulation to the ciliary sulcus and reduces the possibility of pigmentation and glaucoma. The intraocular lens placed on the adjustable intracapsular ring is used in conjunction with the adjustable intracapsular ring. It consists of an optical part and a loop part. The optical part can be any spherical, aspheric or multifocal intraocular lens. The design of the loop can be The intraocular lens can be placed on the inner ring of the capsule, and the intraocular lens can be fixed in the center. It is possible to add through holes or/and blind holes on the inner ring of the capsule for placing sustained-release drugs to effectively reduce and control postoperative inflammation.
对于放置有综合人工晶状体植入体的小儿患者来说,过了成长期之后,可以根据患者需要,置换放置在可调式囊内环上的人工晶状体,还可以在可调式囊内环上再增加一个人工晶状体来改变屈光度,因为可调式囊内环也预留了放置第二个人工晶状体的位置。通过以上方法可以有效解决青少年白内障患者屈光度不断变换的问题。For pediatric patients with integrated intraocular lens implants, after the growth period, the intraocular lens placed on the adjustable intracapsular ring can be replaced according to the needs of the patient, and it can also be added to the adjustable intracapsular ring An intraocular lens is used to change the diopter, because the adjustable intracapsular ring also reserves a place for the second artificial lens. The above methods can effectively solve the problem of continuous diopter changes in adolescent cataract patients.
附图说明Description of the drawings
图1为实施例3所述可调式囊内环的结构示意图;FIG. 1 is a schematic diagram of the structure of the adjustable intracapsular ring described in Example 3;
图2为实施例4所述可调式囊内环的结构示意图;2 is a schematic diagram of the structure of the adjustable intracapsular ring described in Example 4;
图3为实施例5所述可调式囊内环的结构示意图;3 is a schematic diagram of the structure of the adjustable inner ring of the capsule according to the embodiment 5;
图4为实施例6所述可调式囊内环的结构示意图;4 is a schematic diagram of the structure of the adjustable intracapsular ring described in Example 6;
图5为实施例7所述可调式囊内环的结构示意图;Fig. 5 is a schematic structural diagram of the adjustable intra-capsular ring of embodiment 7;
图6为实施例8所述可调式囊内环的结构示意图;6 is a schematic diagram of the structure of the adjustable inner ring of the capsule in Example 8;
图7为实施例9所述可调式囊内环的结构示意图;FIG. 7 is a schematic diagram of the structure of the adjustable inner ring of the capsule according to the embodiment 9;
图8为实施例10所述可调式囊内环的结构示意图;FIG. 8 is a schematic diagram of the structure of the adjustable inner ring of the capsule according to the embodiment 10; FIG.
图9为所述环状主体的外侧面为内凹的圆弧结构的局部放大图;Fig. 9 is a partial enlarged view of a concave arc structure on the outer side of the ring body;
图10为所述环状主体的外侧面为外凸的圆弧结构的局部放大图;Fig. 10 is a partial enlarged view of a convex arc structure on the outer side of the ring body;
图11为所述环状主体的截面形状为梯形的局部放大图;11 is a partial enlarged view of the cross-sectional shape of the ring-shaped main body being a trapezoid;
图12为实施例17所述可调式囊内环的结构示意图;FIG. 12 is a schematic diagram of the structure of the adjustable intracapsular ring of embodiment 17;
图13为实施例18所述可调式囊内环的结构示意图;13 is a schematic diagram of the structure of the adjustable intracapsular ring of embodiment 18;
图14为实施例19所述可调式囊内环的结构示意图;14 is a schematic diagram of the structure of the adjustable intra-capsular ring described in Example 19;
图15为实施例20所述可调式囊内环的结构示意图;15 is a schematic diagram of the structure of the adjustable intracapsular ring of embodiment 20;
图16为实施例21所述可调式囊内环的结构示意图;FIG. 16 is a schematic diagram of the structure of the adjustable intracapsular ring of embodiment 21;
图17为实施例22所述可调式囊内环的结构示意图;17 is a schematic diagram of the structure of the adjustable intra-capsular ring of embodiment 22;
图18为环状主体和凸台的前侧面、后侧面、内侧面的含义指定示意图;Figure 18 is a schematic diagram of the meaning designation of the front side, the back side and the inner side of the ring body and the boss;
图19为实施例26所述用于先天性白内障的综合人工晶状体植入体的结构示意图;19 is a schematic diagram of the structure of the integrated intraocular lens implant for congenital cataract described in Example 26;
图20为实施例27所述用于先天性白内障的综合人工晶状体植入体的结构示意图;20 is a schematic diagram of the structure of the integrated intraocular lens implant for congenital cataract described in Example 27;
图21为实施例28所述用于先天性白内障的综合人工晶状体植入体的结构示意图;21 is a schematic diagram of the structure of the integrated intraocular lens implant for congenital cataract described in Example 28;
图中,1环状主体,11圆弧结构,12连接部,13第二通孔,2凸台,21缺口槽,22第一通孔,23盲孔,H1环状主体的厚度,H2凸台的厚度,A1环状主体的前侧面,B1环状主体的后侧面,C1环状主体的内侧面,D1环状主体的外侧面,A2凸台的前侧面,B2凸台的后侧面,C2凸台的内侧面。In the figure, 1 ring body, 11 arc structure, 12 connecting part, 13 second through hole, 2 boss, 21 notch groove, 22 first through hole, 23 blind hole, H1 thickness of ring body, H2 convex The thickness of the platform, the front side of the A1 ring body, the back side of the B1 ring body, the inner side of the C1 ring body, the outer side of the D1 ring body, the front side of the A2 boss, the back side of the B2 boss, The inner side of the C2 boss.
具体实施方式Detailed ways
下面结合实施例对本发明做进一步说明。The present invention will be further described below in conjunction with the embodiments.
本发明所述用于先天性白内障的综合人工晶状体植入体,包括可调式囊内环100和装配在可调式囊内环100上的人工晶状体200,所述可调式囊内环100,包括环状主体1和用于装配人工晶状体的凸台2。可调式囊内环100的环状主体1、凸台2、人工晶状体200均由具有生物相容性的材料制成;所述具有生物相容性的材料中可以不添加或添加可聚合染料。当添加不同颜色染料后,制成的可调式囊内环100呈现不同颜色,便于在手术植入时使囊内环清晰可辨。所述具有生物相容性的材料可以为硅胶、聚甲基丙烯酸甲酯、疏水性丙烯酸酯、交联聚烯烃材料。本发明中提到的缓释药物可以有效减少和控制术后炎症。此外,本发明所述第一通孔22、第二通孔13和盲孔23的形状除本说明书中列举的形状外,还可以是其他形状,只要能实现本发明所述功能即可。The integrated intraocular lens implant for congenital cataracts of the present invention includes an adjustable intracapsular ring 100 and an intraocular lens 200 assembled on the adjustable intracapsular ring 100. The adjustable intracapsular ring 100 includes a ring A shaped body 1 and a boss 2 for assembling an intraocular lens. The annular body 1, the boss 2, and the intraocular lens 200 of the adjustable intracapsular ring 100 are all made of biocompatible materials; the biocompatible materials may not be added or added with polymerizable dyes. When dyes of different colors are added, the manufactured adjustable intracapsular ring 100 presents different colors, so that the intracapsular ring can be clearly distinguished during surgical implantation. The material with biocompatibility can be silica gel, polymethyl methacrylate, hydrophobic acrylate, and cross-linked polyolefin material. The sustained-release medicine mentioned in the present invention can effectively reduce and control postoperative inflammation. In addition, the shape of the first through hole 22, the second through hole 13 and the blind hole 23 of the present invention may be other shapes in addition to the shapes listed in this specification, as long as the functions described in the present invention can be realized.
(一)不同类型的可调式囊内环(1) Different types of adjustable intracapsular rings
实施例1Example 1
本实施例所述可调式囊内环,包括环状主体1和用于装配人工晶状体的凸台2,所述凸台2设置在环状主体1的内侧面,当可调式囊内环植入囊袋后,环状主体1的外圆周可与囊袋内侧面接触,凸台2位于环状主体1厚度的下部,所述环状主体1的厚度H1大于凸台2的厚度H2,凸台2的前侧面低于环状主体1的前侧面,凸台2的后侧面高于环状主体1的后侧面,所述环状主体1为闭环结构,环状主体1由两段或两段以上圆弧结构11通过连接部12连接而成,所述连接部12为V形或U形结构,所述V形或U形结构的开口朝外,所述环状主体1与凸台2为一体成型结构。The adjustable intracapsular ring of this embodiment includes a ring-shaped body 1 and a boss 2 for assembling an intraocular lens. The boss 2 is provided on the inner side of the ring body 1. When the adjustable intracapsular ring is implanted After the capsular bag, the outer circumference of the ring body 1 can be in contact with the inner surface of the capsular bag, the boss 2 is located at the lower part of the thickness of the ring body 1, the thickness H1 of the ring body 1 is greater than the thickness H2 of the boss 2, the boss The front side of 2 is lower than the front side of the ring body 1, and the rear side of the boss 2 is higher than the back side of the ring body 1. The ring body 1 is a closed-loop structure, and the ring body 1 consists of two or two sections The above arc structure 11 is connected by a connecting portion 12, the connecting portion 12 is a V-shaped or U-shaped structure, the opening of the V-shaped or U-shaped structure faces outward, and the ring-shaped body 1 and the boss 2 are One-piece structure.
实施例2Example 2
本实施例所述可调式囊内环,包括环状主体1和用于装配人工晶状体的凸台 2,所述凸台2设置在环状主体1的内侧面,当可调式囊内环植入囊袋后,环状主体1的外圆周可与囊袋内侧面接触,凸台2位于环状主体1厚度的上部,所述环状主体1的厚度H1大于凸台2的厚度H2,凸台2的前侧面低于环状主体1的前侧面,凸台2的后侧面高于环状主体1的后侧面,所述环状主体1为C形开环结构,环状主体1为一段圆弧结构11构成,所述环状主体1与凸台2为一体成型结构。The adjustable intracapsular ring of this embodiment includes a ring-shaped body 1 and a boss 2 for assembling an intraocular lens. The boss 2 is provided on the inner surface of the ring body 1. When the adjustable intracapsular ring is implanted After the capsular bag, the outer circumference of the ring body 1 can contact the inner surface of the capsular bag, the boss 2 is located at the upper part of the thickness of the ring body 1, the thickness H1 of the ring body 1 is greater than the thickness H2 of the boss 2, the boss The front side of 2 is lower than the front side of the ring body 1, and the rear side of the boss 2 is higher than the back side of the ring body 1. The ring body 1 has a C-shaped open-loop structure, and the ring body 1 is a section of circle. The arc structure 11 is formed, and the ring-shaped body 1 and the boss 2 are integrally formed.
实施例3Example 3
本实施例所述可调式囊内环,见图1,包括环状主体1和用于装配人工晶状体的凸台2,所述环状主体1与凸台2为一体成型结构,所述环状主体1为C形开环结构,所述凸台2设置在环状主体1的内侧面,环状主体1为一段圆弧结构11构成,所述环状主体1的内侧面设置有两个凸台2,两个凸台2之间设置有缺口槽21,环状主体1的厚度H1大于凸台2的厚度H2,凸台2位于环状主体1厚度的中部,凸台2的前侧面低于环状主体1的前侧面,凸台2的后侧面高于环状主体1的后侧面。当可调式囊内环植入囊袋后,环状主体1的外圆周可与囊袋内侧面接触。本实施例中,所述环状主体1的外侧面为平面结构,所述环状主体1的截面形状为矩形,所述凸台2的截面形状为矩形。The adjustable intracapsular ring described in this embodiment is shown in Fig. 1, and includes a ring-shaped body 1 and a boss 2 for assembling an intraocular lens. The ring-shaped body 1 and the boss 2 are an integral structure. The main body 1 has a C-shaped open-loop structure, the boss 2 is provided on the inner side of the ring-shaped main body 1, and the ring-shaped main body 1 is composed of a section of arc structure 11, and the inner side of the ring-shaped main body 1 is provided with two protrusions. A notch 21 is provided between the two bosses 2. The thickness H1 of the ring body 1 is greater than the thickness H2 of the boss 2. The boss 2 is located in the middle of the thickness of the ring body 1, and the front side of the boss 2 is low On the front side of the ring body 1, the back side of the boss 2 is higher than the back side of the ring body 1. After the adjustable inner ring of the capsule is implanted in the capsule, the outer circumference of the annular body 1 can contact the inner surface of the capsule. In this embodiment, the outer surface of the ring-shaped body 1 is a plane structure, the cross-sectional shape of the ring-shaped body 1 is a rectangle, and the cross-sectional shape of the boss 2 is a rectangle.
实施例4Example 4
本实施例所述可调式囊内环,见图2,包括环状主体1和用于装配人工晶状体的凸台2,所述环状主体1与凸台2为一体成型结构,所述环状主体1为闭环结构,所述凸台2设置在环状主体1的内侧面,环状主体1由两段圆弧结构11通过连接部12连接而成,所述连接部12为V形结构,所述V形结构的开口朝外,所述环状主体1的内侧面设置有两个凸台2,两个凸台2之间设置有缺口槽21,环状主体1的厚度H1大于凸台2的厚度H2,凸台2位于环状主体1厚度的中部,凸台2的前侧面低于环状主体1的前侧面,凸台2的后侧面高于环状主体1的后侧面。所述凸台2上设置有第一通孔22;所述第一通孔22为腰形的通孔,所述第一通孔22用于保证前后房水的流动或用于放置缓释药物。当可调式囊内环植入囊袋后,所述环状主体1的外圆周可与囊袋内侧面接触。本实施例中,所述环状主体1的截面形状为矩形,所述凸台2的截面形状为矩形。The adjustable intracapsular ring described in this embodiment is shown in Fig. 2. It includes a ring-shaped body 1 and a boss 2 for assembling an intraocular lens. The ring-shaped body 1 and the boss 2 are integrally formed. The main body 1 has a closed-loop structure. The boss 2 is provided on the inner side of the ring-shaped main body 1. The ring-shaped main body 1 is formed by connecting two arc structures 11 through a connecting portion 12, and the connecting portion 12 is a V-shaped structure. The opening of the V-shaped structure faces outward, the inner side of the ring-shaped body 1 is provided with two bosses 2, and a gap groove 21 is provided between the two bosses 2, and the thickness H1 of the ring-shaped body 1 is greater than that of the bosses. The thickness of the boss 2 is H2, the boss 2 is located in the middle of the thickness of the ring body 1, the front side of the boss 2 is lower than the front side of the ring body 1, and the back side of the boss 2 is higher than the back side of the ring body 1. The boss 2 is provided with a first through hole 22; the first through hole 22 is a waist-shaped through hole, and the first through hole 22 is used to ensure the flow of front and back aqueous humor or to place a slow-release drug . After the adjustable inner ring of the capsule is implanted in the capsule, the outer circumference of the annular body 1 can contact the inner surface of the capsule. In this embodiment, the cross-sectional shape of the annular body 1 is rectangular, and the cross-sectional shape of the boss 2 is rectangular.
实施例5Example 5
本实施例所述可调式囊内环,见图3,包括环状主体1和用于装配人工晶状 体的凸台2,所述环状主体1与凸台2为一体成型结构,所述环状主体1为C形开环结构,所述凸台2设置在环状主体1的内侧面,环状主体1为一段圆弧结构11构成,所述环状主体1的内侧面设置有两个凸台2,两个凸台2之间设置有缺口槽21,环状主体1的厚度H1大于凸台2的厚度H2,凸台2位于环状主体1厚度的中部,凸台2的前侧面低于环状主体1的前侧面,凸台2的后侧面高于环状主体1的后侧面。所述凸台2上设置有第一通孔22;所述第一通孔22为圆形的通孔,所述环状主体1上设置有第二通孔13,所述第二通孔13为圆形的通孔,所述第一通孔22和第二通孔13用于保证前后房水的流动或用于放置缓释药物。当可调式囊内环植入囊袋后,所述环状主体1的外圆周可与囊袋内侧面接触。本实施例中,所述环状主体1的截面形状为矩形,所述凸台2的截面形状为矩形。The adjustable intracapsular ring described in this embodiment is shown in Fig. 3, and includes a ring-shaped body 1 and a boss 2 for assembling an intraocular lens. The ring-shaped body 1 and the boss 2 are integrally formed. The main body 1 has a C-shaped open-loop structure, the boss 2 is provided on the inner side of the ring-shaped main body 1, and the ring-shaped main body 1 is composed of a section of arc structure 11, and the inner side of the ring-shaped main body 1 is provided with two protrusions. A notch 21 is provided between the two bosses 2. The thickness H1 of the ring body 1 is greater than the thickness H2 of the boss 2. The boss 2 is located in the middle of the thickness of the ring body 1, and the front side of the boss 2 is low On the front side of the ring body 1, the back side of the boss 2 is higher than the back side of the ring body 1. The boss 2 is provided with a first through hole 22; the first through hole 22 is a circular through hole, and the annular body 1 is provided with a second through hole 13, and the second through hole 13 It is a circular through hole, and the first through hole 22 and the second through hole 13 are used to ensure the flow of aqueous humor before and after or to place a slow-release drug. After the adjustable inner ring of the capsule is implanted in the capsule, the outer circumference of the annular body 1 can contact the inner surface of the capsule. In this embodiment, the cross-sectional shape of the annular body 1 is rectangular, and the cross-sectional shape of the boss 2 is rectangular.
实施例6Example 6
本实施例所述可调式囊内环,见图4,包括环状主体1和用于装配人工晶状体的凸台2,所述环状主体1与凸台2为一体成型结构,所述环状主体1为C形开环结构,所述凸台2设置在环状主体1的内侧面,所述凸台2的弧形与实施例3不同,环状主体1为一段圆弧结构11构成,所述环状主体1的内侧面设置有两个凸台2,两个凸台2之间设置有缺口槽21,环状主体1的厚度H1大于凸台2的厚度H2,凸台2位于环状主体1厚度的中部,凸台2的前侧面低于环状主体1的前侧面,凸台2的后侧面高于环状主体1的后侧面。所述凸台2上设置有第一通孔22;所述第一通孔22为腰形的通孔,所述第一通孔22用于保证前后房水的流动或用于放置缓释药物。当可调式囊内环植入囊袋后,所述环状主体1的外圆周可与囊袋内侧面接触。本实施例中,所述环状主体1的截面形状为矩形。The adjustable intracapsular ring described in this embodiment is shown in Fig. 4, and includes a ring-shaped body 1 and a boss 2 for assembling an intraocular lens. The ring-shaped body 1 and the boss 2 are an integral structure. The main body 1 has a C-shaped open-loop structure, and the boss 2 is provided on the inner side of the ring-shaped main body 1. The arc shape of the boss 2 is different from that of the embodiment 3. The ring-shaped main body 1 is composed of a circular arc structure 11, The inner side of the ring-shaped body 1 is provided with two bosses 2, and a gap groove 21 is provided between the two bosses 2. The thickness H1 of the ring-shaped body 1 is greater than the thickness H2 of the bosses 2, and the bosses 2 are located in the ring In the middle of the thickness of the main body 1, the front side of the boss 2 is lower than the front side of the ring body 1, and the back side of the boss 2 is higher than the back side of the ring body 1. The boss 2 is provided with a first through hole 22; the first through hole 22 is a waist-shaped through hole, and the first through hole 22 is used to ensure the flow of front and back aqueous humor or to place a slow-release drug . After the adjustable inner ring of the capsule is implanted in the capsule, the outer circumference of the annular body 1 can contact the inner surface of the capsule. In this embodiment, the cross-sectional shape of the ring-shaped body 1 is rectangular.
实施例7Example 7
本实施例所述可调式囊内环,见图5,与实施例6不同之处在于,所述环状主体1上设置有第二通孔13,所述第二通孔13为圆形的通孔,所述第二通孔13用于保证前后房水的流动或用于放置缓释药物。其余特征与实施例6所述一致。The adjustable bladder inner ring of this embodiment is shown in Fig. 5. The difference from embodiment 6 is that a second through hole 13 is provided on the annular body 1, and the second through hole 13 is circular Through holes, the second through holes 13 are used to ensure the flow of aqueous humor before and after or to place slow-release drugs. The remaining features are the same as those described in Example 6.
实施例8Example 8
本实施例所述可调式囊内环,见图6,包括环状主体1和用于装配人工晶状体的凸台2,所述环状主体1与凸台2为一体成型结构,所述环状主体1为闭环结构,所述凸台2设置在环状主体1的内侧面,环状主体1由两段圆弧结构11通过连接部12连接而成,所述连接部12为U形结构,所述U形结构的开口朝 外,所述环状主体1的内侧面设置有两个凸台2,凸台2的弧形与实施例3不同,两个凸台2之间设置有缺口槽21,环状主体1的厚度H1大于凸台2的厚度H2,凸台2位于环状主体1厚度的中部,凸台2的前侧面低于环状主体1的前侧面,凸台2的后侧面高于环状主体1的后侧面。当可调式囊内环植入囊袋后,所述环状主体1的外圆周可与囊袋内侧面接触。本实施例中,所述环状主体1的截面形状为矩形,所述凸台2的截面形状为矩形。The adjustable intracapsular ring of this embodiment is shown in Fig. 6, and includes a ring-shaped body 1 and a boss 2 for assembling an intraocular lens. The ring-shaped body 1 and the boss 2 are an integral structure. The main body 1 has a closed-loop structure. The boss 2 is provided on the inner side of the ring-shaped main body 1. The ring-shaped main body 1 is formed by connecting two arc structures 11 through a connecting portion 12, and the connecting portion 12 is a U-shaped structure. The opening of the U-shaped structure faces outward, and two bosses 2 are provided on the inner side of the ring-shaped body 1. The arc shape of the bosses 2 is different from that of the third embodiment, and a notch groove is provided between the two bosses 2 21. The thickness H1 of the ring body 1 is greater than the thickness H2 of the boss 2. The boss 2 is located in the middle of the thickness of the ring body 1. The front side of the boss 2 is lower than the front side of the ring body 1, and the back of the boss 2 The side surface is higher than the rear side surface of the ring body 1. After the adjustable inner ring of the capsule is implanted in the capsule, the outer circumference of the annular body 1 can contact the inner surface of the capsule. In this embodiment, the cross-sectional shape of the annular body 1 is rectangular, and the cross-sectional shape of the boss 2 is rectangular.
实施例9Example 9
本实施例所述可调式囊内环,见图7,与实施例8不同之处在于,所述凸台2上设置有第一通孔22;所述第一通孔22为圆形的通孔,所述环状主体1上设置有第二通孔13,所述第二通孔13为圆形的通孔,所述第一通孔22和第二通孔13用于保证前后房水的流动或用于放置缓释药物,有效保证前后房水的流动。其余特征与实施例8所述一致。The adjustable bladder inner ring of this embodiment is shown in Fig. 7. The difference from embodiment 8 is that the boss 2 is provided with a first through hole 22; the first through hole 22 is a circular through hole. Hole, the ring-shaped body 1 is provided with a second through hole 13, the second through hole 13 is a circular through hole, the first through hole 22 and the second through hole 13 are used to ensure the front and rear aqueous humor It can be used to place slow-release drugs to effectively ensure the flow of aqueous humor before and after. The remaining features are the same as those described in Example 8.
实施例10Example 10
本实施例所述可调式囊内环,见图8,与实施例4不同之处在于,所述环状主体1上设置有第二通孔13,所述第二通孔13为圆形的通孔,所述第二通孔13用于保证前后房水的流动或用于放置缓释药物。其余特征与实施例4所述一致。The adjustable bladder inner ring of this embodiment is shown in Fig. 8. The difference from embodiment 4 is that a second through hole 13 is provided on the annular body 1, and the second through hole 13 is circular Through holes, the second through holes 13 are used to ensure the flow of aqueous humor before and after or to place slow-release drugs. The remaining features are the same as those described in Example 4.
实施例11Example 11
本实施例所述可调式囊内环,与实施例4不同之处在于,所述环状主体1上设置有第二通孔13,所述第二通孔13为腰形的通孔,有效保证前后房水的流动。其余特征与实施例4所述一致。The adjustable inner bag ring of this embodiment is different from the embodiment 4 in that the ring-shaped body 1 is provided with a second through hole 13, and the second through hole 13 is a waist-shaped through hole, which is effective Ensure the flow of aqueous humor before and after. The remaining features are the same as those described in Example 4.
实施例12Example 12
本实施例所述可调式囊内环,与实施例4不同之处在于,所述环状主体1上设置有第二通孔13,所述第二通孔13为多边形的通孔,有效保证前后房水的流动。其余特征与实施例4所述一致。The adjustable bladder ring of this embodiment is different from the embodiment 4 in that the ring body 1 is provided with a second through hole 13, and the second through hole 13 is a polygonal through hole, which effectively guarantees The flow of aqueous humor before and after. The remaining features are the same as those described in Example 4.
实施例13Example 13
本实施例所述可调式囊内环,与实施例8不同之处在于,所述凸台2上设置有第一通孔22;所述第一通孔22为多边形的通孔,有效保证前后房水的流动。其余特征与实施例8所述一致。The adjustable bladder inner ring of this embodiment is different from the embodiment 8 in that the boss 2 is provided with a first through hole 22; the first through hole 22 is a polygonal through hole, which effectively guarantees the front and rear The flow of aqueous humor. The remaining features are the same as those described in Example 8.
实施例14Example 14
本实施例所述可调式囊内环,与实施例4不同之处在于,所述环状主体1的 外侧面为内凹的圆弧结构,见图9局部放大图。其余特征与实施例4所述一致。The adjustable inner balloon ring of this embodiment is different from the embodiment 4 in that the outer surface of the ring body 1 is a concave arc structure, as shown in Fig. 9 a partial enlarged view. The remaining features are the same as those described in Example 4.
实施例15Example 15
本实施例所述可调式囊内环,与实施例4不同之处在于,所述环状主体1的外侧面为外凸的圆弧结构,见图10局部放大图。其余特征与实施例4所述一致。The adjustable inner balloon ring of this embodiment is different from the embodiment 4 in that the outer surface of the ring body 1 is a convex arc structure, as shown in Fig. 10, a partial enlarged view. The remaining features are the same as those described in Example 4.
实施例16Example 16
本实施例所述可调式囊内环,与实施例3不同之处在于,所述环状主体1的截面形状为梯形,见图11局部放大图,所述凸台2的截面形状为梯形。其余特征与实施例4所述一致。The adjustable inner balloon ring of this embodiment is different from the third embodiment in that the cross-sectional shape of the annular body 1 is a trapezoid, as shown in FIG. 11, a partial enlarged view, and the cross-sectional shape of the boss 2 is a trapezoid. The remaining features are the same as those described in Example 4.
实施例17Example 17
本实施例所述可调式囊内环,见图12,与实施例4不同之处在于,所述凸台2的前侧面上还设置有用于放置缓释药物的盲孔23,所述盲孔为圆形,所述凸台2的内侧面设置有用于放置缓释药物的盲孔23,所述盲孔为腰形槽,所述环状主体1的前侧面上也设置有用于放置缓释药物的盲孔23,所述盲孔为圆形。其余特征与实施例4所述一致。The adjustable inner ring of the capsule in this embodiment is shown in Fig. 12. The difference from embodiment 4 is that the front side of the boss 2 is also provided with a blind hole 23 for placing a slow-release drug. It is circular, the inner surface of the boss 2 is provided with a blind hole 23 for placing slow-release drugs, the blind hole is a waist-shaped groove, and the front side of the ring-shaped body 1 is also provided with a blind hole 23 for placing the slow-release drug. The blind hole 23 of the medicine, the blind hole is circular. The remaining features are the same as those described in Example 4.
实施例18Example 18
本实施例所述可调式囊内环,见图13,与实施例17不同之处在于,所述环状主体1的外侧面为内凹的圆弧结构。其余特征与实施例17所述一致。The adjustable bladder inner ring of this embodiment is shown in Fig. 13. The difference from the embodiment 17 is that the outer surface of the ring body 1 is a concave arc structure. The remaining features are the same as those described in Example 17.
实施例19Example 19
本实施例所述可调式囊内环,见图14,与实施例10不同之处在于,所述环状主体1的外侧面为外凸的圆弧结构;所述凸台2的前侧面上还设置有用于放置缓释药物的盲孔23,所述盲孔为圆形,所述凸台2的内侧面设置有用于放置缓释药物的盲孔23,所述盲孔为腰形槽。其余特征与实施例10所述一致。The adjustable balloon inner ring of this embodiment is shown in Fig. 14. The difference from embodiment 10 is that the outer surface of the ring body 1 is a convex arc structure; the front side of the boss 2 A blind hole 23 for placing a slow-release drug is also provided, the blind hole is circular, the inner side of the boss 2 is provided with a blind hole 23 for placing a slow-release drug, and the blind hole is a waist-shaped groove. The remaining features are the same as those described in Example 10.
实施例20Example 20
本实施例所述可调式囊内环,见图15,与实施例3不同之处在于,所述环状主体1的外侧面为内凹的圆弧结构;所述凸台2的内侧面设置有用于放置缓释药物的盲孔23,所述盲孔为腰形槽。其余特征与实施例3所述一致。The adjustable balloon inner ring of this embodiment is shown in Fig. 15. The difference from embodiment 3 is that the outer surface of the ring body 1 is a concave arc structure; the inner surface of the boss 2 is provided There is a blind hole 23 for placing sustained-release drugs, and the blind hole is a waist-shaped groove. The remaining features are the same as those described in Example 3.
实施例21Example 21
本实施例所述可调式囊内环,见图16,与实施例6不同之处在于,所述凸台2的前侧面上还设置有用于放置缓释药物的盲孔23,所述盲孔为圆形,所述凸台2的内侧面设置有用于放置缓释药物的盲孔23,所述盲孔为腰形槽,所述 环状主体1上设置有第二通孔13,所述第二通孔13为圆形的通孔,所述第二通孔13用于保证前后房水的流动或用于放置缓释药物,所述环状主体1的外侧面为外凸的圆弧结构。其余特征与实施例6所述一致。The adjustable sac inner ring of this embodiment is shown in Fig. 16. The difference from embodiment 6 is that the front side of the boss 2 is also provided with a blind hole 23 for placing a slow-release drug. In the shape of a circle, the inner surface of the boss 2 is provided with a blind hole 23 for placing sustained-release drugs, the blind hole is a waist-shaped groove, and the ring-shaped body 1 is provided with a second through hole 13, the The second through hole 13 is a circular through hole, and the second through hole 13 is used to ensure the flow of aqueous humor or to place slow-release drugs. The outer surface of the ring body 1 is a convex arc structure. The remaining features are the same as those described in Example 6.
实施例22Example 22
本实施例所述可调式囊内环,见图17,包括环状主体1和用于装配人工晶状体的凸台2,所述环状主体1与凸台2为一体成型结构,所述环状主体1为闭环结构,所述凸台2设置在环状主体1的内侧面,环状主体1由两段圆弧结构11通过连接部12连接而成,所述连接部12为V形结构,所述V形结构的开口朝外,所述连接部12的厚度与环状主体1的厚度相同。所述环状主体1的内侧面设置有两个凸台2,两个凸台2之间设置有缺口槽21,环状主体1的厚度H1大于凸台2的厚度H2,凸台2位于环状主体1厚度的下部,凸台2的前侧面低于环状主体1的前侧面,凸台2的后侧面与环状主体1的后侧面处于同一平面。所述凸台2上设置有第一通孔22;所述第一通孔22为腰形的通孔,所述第一通孔22用于保证前后房水的流动或用于放置缓释药物。当可调式囊内环植入囊袋后,所述环状主体1的外圆周可与囊袋内侧面接触。The adjustable intracapsular ring of this embodiment is shown in Fig. 17, and includes a ring-shaped body 1 and a boss 2 for assembling an intraocular lens. The ring-shaped body 1 and the boss 2 are an integral structure. The main body 1 has a closed-loop structure. The boss 2 is provided on the inner side of the ring-shaped main body 1. The ring-shaped main body 1 is formed by connecting two arc structures 11 through a connecting portion 12, and the connecting portion 12 is a V-shaped structure. The opening of the V-shaped structure faces outward, and the thickness of the connecting portion 12 is the same as the thickness of the annular body 1. The inner side of the ring-shaped body 1 is provided with two bosses 2, and a gap groove 21 is provided between the two bosses 2. The thickness H1 of the ring-shaped body 1 is greater than the thickness H2 of the bosses 2, and the bosses 2 are located in the ring At the lower part of the thickness of the shaped body 1, the front side of the boss 2 is lower than the front side of the ring body 1, and the back side of the boss 2 and the back side of the ring body 1 are on the same plane. The boss 2 is provided with a first through hole 22; the first through hole 22 is a waist-shaped through hole, and the first through hole 22 is used to ensure the flow of front and back aqueous humor or to place a slow-release drug . After the adjustable inner ring of the capsule is implanted in the capsule, the outer circumference of the annular body 1 can contact the inner surface of the capsule.
实施例23Example 23
本实施例所述可调式囊内环,见图18,与实施例10不同之处在于,所述凸台2的前侧面上还设置有用于放置缓释药物的盲孔23,所述盲孔为圆形,所述凸台2的内侧面设置有用于放置缓释药物的盲孔23,所述盲孔为腰形槽,所述环状主体1的外侧面为内凹的圆弧结构。其余特征与实施例10所述一致。The adjustable inner ring of the capsule in this embodiment is shown in Fig. 18. The difference from the embodiment 10 is that the front side of the boss 2 is also provided with a blind hole 23 for placing a slow-release drug. In a circular shape, the inner surface of the boss 2 is provided with a blind hole 23 for placing a slow-release drug, the blind hole is a waist-shaped groove, and the outer surface of the ring body 1 has a concave arc structure. The remaining features are the same as those described in Example 10.
(二)用于先天性白内障的综合人工晶状体植入体的装配实施例(2) Assembly example of integrated intraocular lens implant for congenital cataract
实施例24Example 24
本实施例所述用于先天性白内障的综合人工晶状体植入体,包括可调式囊内环100和装配在可调式囊内环100上的人工晶状体200;所述可调式囊内环100包括环状主体1和用于装配人工晶状体的凸台2,所述凸台2设置在环状主体1的内侧面,所述环状主体1为闭环结构,当可调式囊内环植入囊袋后,环状主体1的外圆周可与囊袋内侧面接触。The integrated intraocular lens implant for congenital cataracts described in this embodiment includes an adjustable intracapsular ring 100 and an intraocular lens 200 assembled on the adjustable intracapsular ring 100; the adjustable intracapsular ring 100 includes a ring A shaped body 1 and a boss 2 for assembling an intraocular lens. The boss 2 is arranged on the inner side of the ring-shaped body 1. The ring-shaped body 1 has a closed-loop structure. When the adjustable intracapsular ring is implanted in the capsular bag , The outer circumference of the ring body 1 can be in contact with the inner surface of the capsular bag.
实施例25Example 25
本实施例所述用于先天性白内障的综合人工晶状体植入体,包括可调式囊内环100和装配在可调式囊内环100上的人工晶状体200;所述可调式囊内环100 包括环状主体1和用于装配人工晶状体的凸台2,所述凸台2设置在环状主体1的内侧面,所述环状主体1为C形开环结构,当可调式囊内环植入囊袋后,环状主体1的外圆周可与囊袋内侧面接触。The integrated intraocular lens implant for congenital cataracts described in this embodiment includes an adjustable intracapsular ring 100 and an intraocular lens 200 assembled on the adjustable intracapsular ring 100; the adjustable intracapsular ring 100 includes a ring A shaped body 1 and a boss 2 for assembling an intraocular lens. The boss 2 is arranged on the inner surface of the ring body 1. The ring body 1 has a C-shaped open ring structure. When the adjustable intracapsular ring is implanted After the capsular bag, the outer circumference of the ring-shaped body 1 can contact the inner surface of the capsular bag.
实施例26Example 26
本实施例所述用于先天性白内障的综合人工晶状体植入体,见图19,包括可调式囊内环100和装配在可调式囊内环100上的人工晶状体200;所述可调式囊内环100包括环状主体1和用于装配人工晶状体的凸台2,所述凸台2设置在环状主体1的内侧面,所述环状主体1为C形开环结构,当可调式囊内环植入囊袋后,环状主体1的外圆周可与囊袋内侧面接触。The integrated intraocular lens implant for congenital cataract described in this embodiment is shown in Fig. 19, which includes an adjustable intracapsular ring 100 and an intraocular lens 200 assembled on the adjustable intracapsular ring 100; The ring 100 includes a ring body 1 and a boss 2 for assembling an intraocular lens. The boss 2 is arranged on the inner surface of the ring body 1. The ring body 1 has a C-shaped open ring structure. After the inner ring is implanted in the capsular bag, the outer circumference of the annular body 1 can contact the inner surface of the capsular bag.
本实施例中在可调式囊内环100的凸台2前侧面和凸台2后侧面上装配两个不同类型的人工晶状体200,人工晶状体200的光学面可以是球面、非球面、散光或多焦点等光学面中任意一种,人工晶状体200的襻为2个。In this embodiment, two different types of intraocular lenses 200 are assembled on the front side of the boss 2 and the back side of the boss 2 of the adjustable intracapsular ring 100. The optical surface of the intraocular lens 200 can be spherical, aspherical, astigmatic or multi-faceted. There are two haptics of the intraocular lens 200 for any one of the optical surfaces such as the focal point.
本实施例中所使用的可调式囊内环100与实施例6所述可调式囊内环100的不同之处在于,所述凸台2上表面还设置有盲孔23,所述凸台2的内侧面设置有盲孔23,所述环状主体1上也设置有盲孔23。所述盲孔23用于放置缓释药物。其余特征与实施例6所述一致。The difference between the adjustable inner balloon ring 100 used in this embodiment and the adjustable inner balloon ring 100 described in Example 6 is that the upper surface of the boss 2 is also provided with a blind hole 23, and the boss 2 A blind hole 23 is provided on the inner side of the ring, and a blind hole 23 is also provided on the ring-shaped body 1. The blind hole 23 is used for placing sustained-release drugs. The remaining features are the same as those described in Example 6.
实施例27Example 27
本实施例所述用于先天性白内障的综合人工晶状体植入体,见图20,包括可调式囊内环100和装配在可调式囊内环100上的人工晶状体200;所述可调式囊内环100包括环状主体1和用于装配人工晶状体的凸台2,所述凸台2设置在环状主体1的内侧面,所述环状主体1为闭环结构,当可调式囊内环植入囊袋后,环状主体1的外圆周可与囊袋内侧面接触。The integrated intraocular lens implant for congenital cataract described in this embodiment is shown in Fig. 20, which includes an adjustable intracapsular ring 100 and an intraocular lens 200 assembled on the adjustable intracapsular ring 100; the adjustable intracapsular The ring 100 includes a ring body 1 and a boss 2 for assembling an intraocular lens. The boss 2 is arranged on the inner side of the ring body 1. The ring body 1 is a closed ring structure. After being inserted into the capsular bag, the outer circumference of the annular body 1 can be in contact with the inner surface of the capsular bag.
本实施例中在可调式囊内环100的凸台2前侧面上装配一个人工晶状体200,人工晶状体200的光学面可以是球面、非球面、散光或多焦点光学面中任意一种,人工晶状体200的襻为2个。In this embodiment, an intraocular lens 200 is assembled on the front side of the boss 2 of the adjustable intracapsular ring 100. The optical surface of the intraocular lens 200 can be any one of spherical, aspherical, astigmatic or multifocal optical surfaces. The intraocular lens There are 2 loops of 200.
本实施例中所使用的可调式囊内环100,与实施例9不同之处在于,所述凸台2的内侧面设置有盲孔23。所述盲孔23用于放置缓释药物。其余特征与实施例9所述一致。The adjustable inner bag ring 100 used in this embodiment is different from the embodiment 9 in that the inner surface of the boss 2 is provided with a blind hole 23. The blind hole 23 is used for placing sustained-release drugs. The remaining features are the same as those described in Example 9.
实施例28Example 28
本实施例所述用于先天性白内障的综合人工晶状体植入体,见图21,包括可调式囊内环100和装配在可调式囊内环100上的人工晶状体200;所述可调式囊内环100包括环状主体1和用于装配人工晶状体的凸台2,所述凸台2设置在环状主体1的内侧面,所述环状主体1为C形开环结构,当可调式囊内环植入囊袋后,环状主体1的外圆周可与囊袋内侧面接触。The integrated intraocular lens implant for congenital cataract described in this embodiment is shown in Fig. 21. It includes an adjustable intracapsular ring 100 and an intraocular lens 200 assembled on the adjustable intracapsular ring 100; The ring 100 includes a ring body 1 and a boss 2 for assembling an intraocular lens. The boss 2 is arranged on the inner surface of the ring body 1. The ring body 1 has a C-shaped open ring structure. After the inner ring is implanted in the capsular bag, the outer circumference of the annular body 1 can contact the inner surface of the capsular bag.
本实施例中在可调式囊内环100的凸台2后侧面上装配一个人工晶状体200,人工晶状体200的光学面可以是球面、非球面、散光或多焦点光学面中任意一种,人工晶状体200的襻为2个。In this embodiment, an intraocular lens 200 is assembled on the back side of the boss 2 of the adjustable intracapsular ring 100. The optical surface of the intraocular lens 200 can be any one of spherical, aspherical, astigmatic or multifocal optical surfaces. The intraocular lens There are 2 loops of 200.
本实施例中所使用的可调式囊内环100为实施例21所述的可调式囊内环100。The adjustable inner balloon ring 100 used in this embodiment is the adjustable inner balloon ring 100 described in Embodiment 21.
本发明所述用于先天性白内障的综合人工晶状体植入体的使用方法:The method of using the integrated intraocular lens implant for congenital cataracts of the present invention:
(1)首先对白内障患者通过超声乳化术摘除混浊的自然晶状体,再选择适合患者囊袋大小的可调式囊内环100,利用镊子或专用囊内环推注器将囊内环缓慢推入患者囊袋内,并调整可调式囊内环100的位置;(1) First, phacoemulsification is used to remove the cloudy natural lens of the cataract patient, and then select the adjustable intracapsular ring 100 suitable for the size of the patient's capsular bag, and slowly push the intracapsular ring into the patient with tweezers or a special intracapsular injection device. Inside the bag, and adjust the position of the adjustable inner ring 100;
(2)根据患者实际情况,在适当的时候可以在可调式囊内环100的凸台2前侧面或后侧面上放置一个人工晶状体200。根据患者需要在适当的时候可以置换放置在可调式囊内环100上的人工晶状体200,也可以在囊内环上再增加一个人工晶状体200来改变屈光度。(2) According to the actual situation of the patient, an intraocular lens 200 can be placed on the front or back side of the boss 2 of the adjustable intracapsular ring 100 when appropriate. The intraocular lens 200 placed on the adjustable intracapsular ring 100 can be replaced at an appropriate time according to the needs of the patient, or another intraocular lens 200 can be added to the intracapsular ring to change the diopter.
本发明所述用于先天性白内障的综合人工晶状体植入体的制作方法:The manufacturing method of the integrated intraocular lens implant for congenital cataract of the present invention:
可调式囊内环100:经模具注塑成毛坯,进行机械加工成型,再进行研磨抛光、清洗、烘干等后处理,之后进行包装灭菌,通过专用推注器或镊子植入人眼囊袋内。Adjustable inner sac ring 100: It is injection molded into a blank, processed by mechanical processing, and then subjected to post-processing such as grinding, polishing, cleaning, and drying. After that, it is packaged and sterilized, and it is implanted into the human eye sac through a special injection device or tweezers. Inside.
人工晶状体200:经注塑成型,对毛坯进行机械加工,再进行化学处理、清洗、烘干等后处理,之后进行包装灭菌,通过人工晶状体推注器植入人眼囊袋后,放置在囊内环的一侧。本发明所述人工晶状体200可以是现有技术中的人工晶状体或未来开发出来的新型人工晶状体,只要能够装配在本发明所述可调式囊内环100的凸台2上即为本发明所保护的设计构思。Intraocular lens 200: After injection molding, the blank is mechanically processed, and then chemical treatment, cleaning, drying and other post-treatments are carried out, and then packaged and sterilized. After the intraocular lens bolus is implanted in the human eye capsule, it is placed in the capsule One side of the inner ring. The intraocular lens 200 of the present invention may be an intraocular lens in the prior art or a new type of intraocular lens developed in the future. As long as it can be assembled on the boss 2 of the adjustable intracapsular ring 100 of the present invention, it is protected by the present invention. Design concept.
本发明的创新点:The innovation of the present invention:
(1)本发明所述用于先天性白内障的综合人工晶状体植入体,包括可调式囊内环100和装配在可调式囊内环100上的人工晶状体200,所述可调式囊内环100上可以装配一个人工晶状体200。根据患者实际情况,在可调式囊内环100 的凸台2的前侧面或后侧面上放置一个人工晶状体200,也可以根据患者需要置换人工晶状体,还可以在凸台2上再增加一个人工晶状体200来调整患者屈光度。该组合植入体可以分别植入,在白内障去除时先植入可调式囊内环100,以保护小儿囊袋,等到合适的时候再将人工晶状体200植入于可调式囊内环100内,作为二次植入。也可以将可调式囊内环100和人工晶状体200在一次手术内植入。(1) The integrated intraocular lens implant for congenital cataracts of the present invention includes an adjustable intracapsular ring 100 and an intraocular lens 200 assembled on the adjustable intracapsular ring 100. The adjustable intracapsular ring 100 An intraocular lens 200 can be mounted on it. According to the actual situation of the patient, place an intraocular lens 200 on the anterior or posterior side of the boss 2 of the adjustable intracapsular ring 100. The intraocular lens can also be replaced according to the needs of the patient, and another intraocular lens can be added to the boss 2 200 to adjust the diopter of the patient. The combined implants can be implanted separately. When cataracts are removed, the adjustable intracapsular ring 100 is first implanted to protect the pediatric capsular bag. When appropriate, the intraocular lens 200 can be implanted in the adjustable intracapsular ring 100. As a secondary implant. The adjustable intracapsular ring 100 and the intraocular lens 200 can also be implanted in one operation.
(2)本发明所述可调式囊内环100独特的结构设计,使得囊内环可随着小儿囊袋的生长产生相应的尺寸变化,维持囊袋圆形轮廓,帮助维持晶状体囊袋的正常生理位置,防止人工晶状体倾斜和偏心。(2) The unique structural design of the adjustable intracapsular ring 100 of the present invention enables the intracapsular ring to produce corresponding size changes with the growth of the pediatric capsular bag, maintain the circular contour of the capsular bag, and help maintain the normal lens capsular bag Physiological position to prevent tilt and eccentricity of the intraocular lens.
(3)由于人工晶状体是和可调式囊内环的内侧面接触,而不是与囊袋接触,降低了人工晶状体可能与囊袋黏连,不易取出的手术难度。(3) Since the intraocular lens is in contact with the inner surface of the adjustable intracapsular ring instead of the capsular bag, it reduces the surgical difficulty that the intraocular lens may adhere to the capsular bag and is not easy to remove.
(4)当可调式囊内环植入囊袋后,环状主体1的外圆周可与囊袋内侧面接触,可发挥屏障作用及接触性抑制作用,阻止晶状体上皮细胞的增生与移行,减少后发性白内障的发生,防止发生前后囊膜混浊。(4) When the adjustable intracapsular ring is implanted in the capsular bag, the outer circumference of the ring body 1 can contact the inner surface of the capsular bag, which can play a barrier function and contact inhibition effect, prevent the proliferation and migration of lens epithelial cells, and reduce After the occurrence of cataract, to prevent the occurrence of turbidity of the capsule before and after.
(5)所述凸台2上设置有第一通孔22;所述第一通孔22为腰形、多边形或圆形的通孔,所述第一通孔22用于保证前后房水的流动或用于放置缓释药物。所述环形主体1上设置有第二通孔13;所述第二通孔13为腰形、多边形或圆形的通孔,所述第二通孔13用于保证前后房水的流动或用于放置缓释药物。(5) The boss 2 is provided with a first through hole 22; the first through hole 22 is a waist-shaped, polygonal or circular through hole, and the first through hole 22 is used to ensure the front and back of the aqueous humor It is mobile or used to place sustained-release drugs. The annular body 1 is provided with a second through hole 13; the second through hole 13 is a waist-shaped, polygonal, or circular through hole, and the second through hole 13 is used to ensure the flow or use of aqueous humor before and after. Place sustained-release drugs.
(6)所述环形主体1和/或凸台2上设置有用于放置缓释药物的盲孔23,所述盲孔为腰形、多边形或圆形。(6) The annular body 1 and/or the boss 2 are provided with a blind hole 23 for placing a slow-release drug, and the blind hole is waist-shaped, polygonal or circular.
(7)所述环状主体1与凸台2由具有生物相容性的材料制成;所述具有生物相容性的材料中可以不添加或添加可聚合染料,根据需要当在具有生物相容性的材料中添加可聚合染料时,本发明所述可调式囊内环呈现不同颜色,便于在手术植入时使囊内环清晰可辨。(7) The ring-shaped body 1 and the boss 2 are made of biocompatible materials; the biocompatible materials may not be added or added with polymerizable dyes, and when necessary, they may have biological phases. When the polymerizable dye is added to the capacitive material, the adjustable intracapsular ring of the present invention presents different colors, which is convenient for making the intracapsular ring clearly distinguishable during surgical implantation.
以上内容是结合具体的优选实施方式对本发明所作出的进一步详细说明,不能认定本发明的具体实施仅限于这些说明。对于本发明所属领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以作出若干简单推演或替换,都应该视为属于本发明的保护范围。The above content is a further detailed description of the present invention in conjunction with specific preferred embodiments, and it cannot be considered that the specific implementation of the present invention is limited to these descriptions. For those of ordinary skill in the art to which the present invention belongs, several simple deductions or substitutions can be made without departing from the concept of the present invention, which should be regarded as belonging to the protection scope of the present invention.

Claims (14)

  1. 一种用于先天性白内障的综合人工晶状体植入体,其特征在于:包括可调式囊内环(100)和装配在可调式囊内环(100)上的人工晶状体(200);所述可调式囊内环(100)包括环状主体(1)和用于装配人工晶状体的凸台(2),所述凸台(2)设置在环状主体(1)的内侧面,所述环状主体(1)为闭环结构或C形开环结构,当可调式囊内环植入囊袋后,环状主体(1)的外圆周可与囊袋内侧面接触。A comprehensive intraocular lens implant for congenital cataract, which is characterized in that it comprises an adjustable intracapsular ring (100) and an intraocular lens (200) assembled on the adjustable intracapsular ring (100); The adjustable intracapsular ring (100) includes a ring-shaped body (1) and a boss (2) for assembling the intraocular lens. The boss (2) is arranged on the inner side of the ring-shaped body (1). The main body (1) has a closed-loop structure or a C-shaped open-loop structure. After the adjustable intra-capsular ring is implanted in the capsular bag, the outer circumference of the annular main body (1) can be in contact with the inner surface of the capsular bag.
  2. 根据权利要求1所述用于先天性白内障的综合人工晶状体植入体,其特征在于:所述可调式囊内环(100)上装配一个人工晶状体(200)或两个人工晶状体(200)。The integrated intraocular lens implant for congenital cataracts according to claim 1, wherein the adjustable intracapsular ring (100) is equipped with one intraocular lens (200) or two intraocular lenses (200).
  3. 根据权利要求1所述用于先天性白内障的综合人工晶状体植入体,其特征在于:所述人工晶状体(200)装配在凸台(2)的前侧面和/或凸台(2)的后侧面上。The integrated intraocular lens implant for congenital cataracts according to claim 1, characterized in that: the intraocular lens (200) is assembled on the front side of the boss (2) and/or the back of the boss (2) On the side.
  4. 根据权利要求1所述用于先天性白内障的综合人工晶状体植入体,其特征在于:当环状主体(1)为C形开环结构时,环状主体(1)为一段圆弧结构(11)构成;当环状主体(1)为闭环结构时,环状主体(1)由两段或两段以上圆弧结构(11)通过连接部(12)连接而成,所述连接部(12)为V形或U形结构,所述V形或U形结构的开口朝外。The integrated intraocular lens implant for congenital cataracts according to claim 1, characterized in that: when the ring-shaped body (1) has a C-shaped open ring structure, the ring-shaped body (1) has a circular arc structure ( ( 12) It is a V-shaped or U-shaped structure, and the opening of the V-shaped or U-shaped structure faces outward.
  5. 根据权利要求1所述用于先天性白内障的综合人工晶状体植入体,其特征在于:所述环状主体(1)内设置有若干个凸台(2),相邻两个凸台(2)之间设置有缺口槽(21);所述环状主体(1)的厚度(H1)大于凸台(2)的厚度(H2)。The integrated intraocular lens implant for congenital cataracts according to claim 1, characterized in that: the annular body (1) is provided with a plurality of bosses (2), two adjacent bosses (2) A gap groove (21) is arranged between ); the thickness (H1) of the annular body (1) is greater than the thickness (H2) of the boss (2).
  6. 根据权利要求1所述用于先天性白内障的综合人工晶状体植入体,其特征在于:所述环状主体(1)与凸台(2)为一体成型结构。The integrated intraocular lens implant for congenital cataracts according to claim 1, characterized in that the ring-shaped body (1) and the boss (2) are integrally formed.
  7. 根据权利要求1所述用于先天性白内障的综合人工晶状体植入体,其特征在于:所述环状主体(1)的外侧面为平面结构、内凹的圆弧结构或外凸的圆弧结构;所述凸台(2)的截面形状为矩形或梯形。The integrated intraocular lens implant for congenital cataracts according to claim 1, characterized in that: the outer surface of the ring-shaped body (1) is a plane structure, a concave arc structure or a convex arc Structure; the cross-sectional shape of the boss (2) is rectangular or trapezoidal.
  8. 根据权利要求1所述用于先天性白内障的综合人工晶状体植入体,其特征在于:所述凸台(2)上设置有第一通孔(22);所述第一通孔(22)为腰形、 多边形或圆形的通孔,所述第一通孔(22)用于保证前后房水的流动或用于放置缓释药物。The integrated intraocular lens implant for congenital cataracts according to claim 1, characterized in that: the boss (2) is provided with a first through hole (22); the first through hole (22) It is a waist-shaped, polygonal or circular through hole, and the first through hole (22) is used to ensure the flow of aqueous humor before and after or to place a slow-release drug.
  9. 根据权利要求1所述用于先天性白内障的综合人工晶状体植入体,其特征在于:所述环形主体(1)上设置有第二通孔(13);所述第二通孔(13)为腰形、多边形或圆形的通孔,所述第二通孔(13)用于保证前后房水的流动或用于放置缓释药物。The integrated intraocular lens implant for congenital cataracts according to claim 1, characterized in that: the annular body (1) is provided with a second through hole (13); the second through hole (13) It is a waist-shaped, polygonal or circular through hole, and the second through hole (13) is used to ensure the flow of front and back aqueous humor or to place slow-release drugs.
  10. 根据权利要求1所述用于先天性白内障的综合人工晶状体植入体,其特征在于:所述环形主体(1)和/或凸台(2)上设置有用于放置缓释药物的盲孔(23),所述盲孔为腰形、多边形或圆形。The integrated intraocular lens implant for congenital cataracts according to claim 1, characterized in that: the annular body (1) and/or the boss (2) is provided with a blind hole ( 23) The blind hole is waist-shaped, polygonal or circular.
  11. 根据权利要求1所述用于先天性白内障的综合人工晶状体植入体,其特征在于:所述环状主体(1)、凸台(2)和人工晶状体(200)均由具有生物相容性的材料制成;所述具有生物相容性的材料中不添加或添加可聚合染料;所述具有生物相容性的材料为硅胶、聚甲基丙烯酸甲酯、疏水性丙烯酸酯或交联聚烯烃材料。The integrated intraocular lens implant for congenital cataracts according to claim 1, characterized in that: the annular body (1), the boss (2) and the intraocular lens (200) are all made of biocompatible The material with biocompatibility is not added or added with polymerizable dye; the material with biocompatibility is silica gel, polymethyl methacrylate, hydrophobic acrylate or cross-linked polymer Olefin material.
  12. 根据权利要求1所述用于先天性白内障的综合人工晶状体植入体,其特征在于:所述人工晶状体(200)包括光学面和襻;所述人工晶状体(200)的光学面为球面、非球面、散光或多焦点光学面中任意一种,所述人工晶状体(200)的襻为2个或2个以上。The integrated intraocular lens implant for congenital cataracts according to claim 1, characterized in that: the intraocular lens (200) includes an optical surface and a loop; the optical surface of the intraocular lens (200) is spherical, non-spherical Any one of spherical surface, astigmatism or multifocal optical surface, the number of loops of the intraocular lens (200) is 2 or more.
  13. 根据权利要求1所述用于先天性白内障的综合人工晶状体植入体,其特征在于:在使用过程中,按患者的情况,可调式囊内环(100)和人工晶状体(200)在同一次手术中植入。The integrated intraocular lens implant for congenital cataracts according to claim 1, characterized in that: during use, according to the patient's condition, the adjustable intracapsular ring (100) and the intraocular lens (200) are at the same time Implanted during surgery.
  14. 根据权利要求1所述用于先天性白内障的综合人工晶状体植入体,其特征在于:在使用过程中,按患者的情况,可调式囊内环(100)和人工晶状体(200)在多次手术中分别植入。The integrated intraocular lens implant for congenital cataract according to claim 1, characterized in that: during use, according to the patient's condition, the adjustable intracapsular ring (100) and the intraocular lens (200) are used for multiple times They were implanted separately during the operation.
PCT/CN2021/088305 2020-04-20 2021-04-20 Comprehensive intraocular lens implant for congenital cataract WO2021213363A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010311743.6 2020-04-20
CN202010311743.6A CN111467077B (en) 2020-04-20 2020-04-20 Comprehensive artificial lens implant for congenital cataract

Publications (1)

Publication Number Publication Date
WO2021213363A1 true WO2021213363A1 (en) 2021-10-28

Family

ID=71755934

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/088305 WO2021213363A1 (en) 2020-04-20 2021-04-20 Comprehensive intraocular lens implant for congenital cataract

Country Status (2)

Country Link
CN (1) CN111467077B (en)
WO (1) WO2021213363A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111467077B (en) * 2020-04-20 2022-02-15 西安眼得乐医疗科技有限公司 Comprehensive artificial lens implant for congenital cataract

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5628795A (en) * 1995-03-15 1997-05-13 Langerman David W Spare parts for use in ophthalmic surgical procedures
US6797004B1 (en) * 2000-03-02 2004-09-28 Advanced Medical Optics, Inc. Holders for intraocular lenses
US20100204790A1 (en) * 2009-02-09 2010-08-12 Whitsett Jeffrey C Exchangeable intraocular lens device and method of use
CN107205812A (en) * 2015-02-04 2017-09-26 诺华股份有限公司 Asymmetric capsule ring for suppressing capsule opacifiation
US20190183633A1 (en) * 2017-12-20 2019-06-20 Novartis Ag Fluid-filled haptic for an intraocular lens
CN111467077A (en) * 2020-04-20 2020-07-31 西安浦勒生物科技有限公司 Comprehensive artificial lens implant for congenital cataract

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103068340A (en) * 2010-05-31 2013-04-24 拉姆·斯里坎茨·米拉伊 Pupil centered fovea focused optics assembly for intraocular lens
US9757227B2 (en) * 2012-04-20 2017-09-12 Hanita Lenses Intraocular assembly
CN203059976U (en) * 2012-12-27 2013-07-17 中山大学中山眼科中心 Artificial lens
CN103156708B (en) * 2013-02-01 2016-12-28 浙江大学医学院附属第二医院 Intraocular lens and the manufacture method thereof of medicament slow release microcapsule it is inlaid with on button loop
CN106264787B (en) * 2015-05-18 2021-07-06 爱博诺德(苏州)医疗器械有限公司 Artificial iris capable of fixing artificial lens and material and processing method thereof
US20170049560A1 (en) * 2015-08-21 2017-02-23 Scott A. Cherne Intraocular Lens Holder
EP3574868A4 (en) * 2017-02-13 2020-12-02 Kyoto Prefectural Public University Corporation Artificial lens capsule
CN107928869A (en) * 2017-12-07 2018-04-20 胡园园 A kind of artificial pouch

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5628795A (en) * 1995-03-15 1997-05-13 Langerman David W Spare parts for use in ophthalmic surgical procedures
US6797004B1 (en) * 2000-03-02 2004-09-28 Advanced Medical Optics, Inc. Holders for intraocular lenses
US20100204790A1 (en) * 2009-02-09 2010-08-12 Whitsett Jeffrey C Exchangeable intraocular lens device and method of use
CN107205812A (en) * 2015-02-04 2017-09-26 诺华股份有限公司 Asymmetric capsule ring for suppressing capsule opacifiation
US20190183633A1 (en) * 2017-12-20 2019-06-20 Novartis Ag Fluid-filled haptic for an intraocular lens
CN111467077A (en) * 2020-04-20 2020-07-31 西安浦勒生物科技有限公司 Comprehensive artificial lens implant for congenital cataract

Also Published As

Publication number Publication date
CN111467077A (en) 2020-07-31
CN111467077B (en) 2022-02-15

Similar Documents

Publication Publication Date Title
CN108348327B (en) Modular intraocular lens design, tools and methods
US9439755B2 (en) Haptic devices for intraocular lens
Dahan et al. Pseudophakia in children: precautions, technique, and feasibility
CA2800217C (en) Pseudophakic accommodating intraocular lens
CA2644453C (en) Intraocular lens with accommodation
US10426600B2 (en) Accommodating intraocular lens and methods of use
US20110313522A1 (en) Pseudophakic Accommodating Intraocular Lens
US20080086208A1 (en) Foldable Intraocular Lens With Adaptable Haptics
US20070021832A1 (en) Foldable intraocular lens with adaptable haptics
US10010405B2 (en) Haptic devices for intraocular lens
EP3171821B1 (en) Haptic devices for intraocular lens
WO2021213362A1 (en) Adjustable intracapsular ring
WO2021213363A1 (en) Comprehensive intraocular lens implant for congenital cataract
Barrett A new hydrogel intraocular lens design
US20190076236A1 (en) Intraocular Lens for Implantation in a Ciliary Sulcus of an Eye
CN203280538U (en) Intraocular lens
US10555806B2 (en) Method and device for optimizing vision via customization of spherical aberration of eye
WO2019094768A1 (en) Intraocular lens
US10660743B2 (en) Intraocular lens and methods for implanting the same
US20210085449A1 (en) Method of implantation of an intraocular lens in a ciliary sulcus of an eye
US20230120321A1 (en) Three-dimensional intraocular lens scaffold and add-in lens combination and methods of implantation
US20230397984A1 (en) Stable iol base design to support second optic

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21793046

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21793046

Country of ref document: EP

Kind code of ref document: A1